P.1.b.003 Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias? (English)
- New search for: Fallgatter, A. J.
- New search for: Polak, T.
- New search for: Metzger, F.
- New search for: Plichta, M. M.
- New search for: Ringel, T.
- New search for: Ehlis, A. C.
- New search for: Fallgatter, A. J.
- New search for: Polak, T.
- New search for: Metzger, F.
- New search for: Plichta, M. M.
- New search for: Ringel, T.
- New search for: Ehlis, A. C.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
16
;
S218-S219
;
2006
-
ISSN:
- Article (Journal) / Print
-
Title:P.1.b.003 Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias?
-
Contributors:Fallgatter, A. J. ( author ) / Polak, T. ( author ) / Metzger, F. ( author ) / Plichta, M. M. ( author ) / Ringel, T. ( author ) / Ehlis, A. C. ( author )
-
Published in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 16 ; S218-S219
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2006-01-01
-
Size:S218-S219
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.8 / 615.1
- Further information on Dewey Decimal Classification
-
Classification:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 16
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
The serotonin-1Dβ receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosaLevitan, R. D. / Kaplan, A. S. / Masellis, M. / Basile, V. S. / Richter, M. A. / Kennedy, J. L. et al. | 2006
- 7
-
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disordersde Lago, E. / Fernández-Ruiz, J. / Ortega-Gutiérrez, S. / Cabranes, A. / Pryce, G. / Baker, D. / López-Rodríguez, M. / Ramos, J. A. et al. | 2006
- 19
-
Serotonin uptake to lymphocytes of patients with social phobia compared to normal individualsBarkan, T. / Hermesh, H. / Marom, S. / Gurwitz, D. / Weizman, A. / Rehavi, M. et al. | 2006
- 25
-
A hypothalamic endorphinic lesion attenuates acquisition of cocaine self-administration in the ratRoth-Deri, I. / Mayan, R. / Yadid, G. et al. | 2006
- 33
-
Escitalopram versus paroxetine for social anxiety disorder: An analysis of efficacy for different symptom dimensionsStein, D. J. / Andersen, E. W. / Lader, M. et al. | 2006
- 39
-
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male ratsde Jong, T. R. / Snaphaan, L. J. / Pattij, T. / Veening, J. G. / Waldinger, M. D. / Cools, A. R. / Olivier, B. et al. | 2006
- 49
-
Plasma serotonin levels and suicidal behavior in adolescentsTyano, S. / Zalsman, G. / Ofek, H. / Blum, I. / Apter, A. / Wolovik, L. / Sher, L. / Sommerfeld, E. / Harell, D. / Weizman, A. et al. | 2006
- 59
-
Cognitive evaluation of disease-modifying efficacy of Galantamine and Memantine in the APP23 modelVan Dam, D. / De Deyn, P. P. et al. | 2006
- 71
-
Bipolar mania and plasma amino acids: Increased levels of glycineHoekstra, R. / Fekkes, D. / Loonen, A. J. / Pepplinkhuizen, L. / Tuinier, S. / Verhoeven, W. M. et al. | 2006
- 79
-
Antidepressants use in children and adolescents and the risk of suicideWohlfarth, T. D. / van Zwieten, B. J. / Lekkerkerker, F. J. / Gispen-de Wied, C. C. / Ruis, J. R. / Elferink, A. J. / Storosum, J. G. et al. | 2006
- 85
-
Protective effect of vineatrol against kainic acid induced seizures, oxidative stress and on the expression of heat shock proteins in ratsGupta, Y. K. / Briyal, S. et al. | 2006
- 93
-
Placebo-controlled trial of agomelatine in the treatment of major depressive disorderKennedy, S. H. / Emsley, R. et al. | 2006
- 101
-
Effect of vitamin E on memory retention in rats: Possible involvement of cholinergic systemEidi, A. / Eidi, M. / Mahmoodi, G. / Oryan, S. et al. | 2006
- 107
-
Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorderGreen, P. / Hermesh, H. / Monselise, A. / Marom, S. / Presburger, G. / Weizman, A. et al. | 2006
- 115
-
Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in ratsLifschytz, T. / Shalom, G. / Lerer, B. / Newman, M. E. et al. | 2006
- 123
-
Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholismChoi, I. G. / Kee, B. S. / Son, H. G. / Ham, B. J. / Yang, B. H. / Kim, S. H. / Lee, J. S. / Son, B. K. / Lee, B. Y. / Lee, S. Y. et al. | 2006
- 129
-
Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in miceKuzmin, A. / Johansson, B. r. / Gimenez, L. / Ögren, S. O. / Fredholm, B. B. et al. | 2006
- 137
-
Alterations in DHEA metabolism in schizophrenia: Two-month case-control studyRitsner, M. / Gibel, A. / Ram, E. / Maayan, R. / Weizman, A. et al. | 2006
- 147
-
Effects of α-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamineWan, F. J. / Tung, C. S. / Shiah, I. S. / Lin, H. C. et al. | 2006
- 155
-
The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedsideStrous, R. D. / Maayan, R. / Weizman, A. et al. | 2006
- 170
-
Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brainYu, L. / Zhang, Y. / Ma, R. / Bao, L. / Fang, J. / Yu, T. et al. | 2006
- 178
-
The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3AHaduch, A. / Wójcikowski, J. / Daniel, W. A. et al. | 2006
- 187
-
Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatmentCohen, D. / Dekker, J. J. / Peen, J. / Gispen-de Wied, C. C. et al. | 2006
- 195
-
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injuryMicale, V. / Incognito, T. / Ignoto, A. / Rampello, L. / Spartà, M. / Drago, F. et al. | 2006
- 204
-
Caffeine modulates P50 auditory sensory gating in healthy subjectsGhisolfi, E. S. / Schuch, A. / Strimitzer, I. M. / Luersen, G. / Martins, F. o. / Ramos, F. L. / Becker, J. / Lara, D. R. et al. | 2006
- 211
-
Distinct gene expression profiles in adult rat brains after acute MK-801 and cocaine treatmentsStorvik, M. / Tiikkainen, P. / van Iersel, M. / Wong, G. et al. | 2006
- 220
-
α-[11C]Methyl-l-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attemptersLeyton, M. / Paquette, V. / Gravel, P. / Rosa-Neto, P. / Weston, F. / Diksic, M. / Benkelfat, C. et al. | 2006
- 224
-
ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disordersVan den Brink, W. / Montgomery, S. A. / Van Ree, J. M. / van Zwieten-Boot, B. J. et al. | 2006
- 233
-
Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectableMedori, R. / Mannaert, E. / Gründer, G. et al. | 2006
- 241
-
Hypofunction of the dorsal hippocampal NMDA receptors impairs retrieval of memory to partially presented foreground context in a single-trial fear conditioning in ratsMelik, E. / Babar, E. / Ozen, E. / Ozgunen, T. et al. | 2006
- 248
-
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatmentHwang, R. / Shinkai, T. / Deluca, V. / Macciardi, F. / Potkin, S. / Meltzer, H. Y. / Kennedy, J. L. et al. | 2006
- 260
-
Immobilization stress causes extra-cellular oxidant–antioxidant imbalance in rats: Restoration by L-NAME and vitamin ENadeem, A. / Masood, A. / Masood, N. / Gilani, R. A. / Shah, Z. A. et al. | 2006
- 268
-
Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophreniaDe Luca, V. / Zai, G. / Tharmalingam, S. / de Bartolomeis, A. / Wong, G. / Kennedy, J. L. et al. | 2006
- 272
-
Allopregnanolone produces hyperphagia by reducing neophobia without altering food palatabilityFudge, M. A. / Kavaliers, M. / Ossenkopp, K. P. et al. | 2006
- 281
-
A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymiaZanardi, R. / Smeraldi, E. et al. | 2006
- 288
-
Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonistDíaz-Mataix, L. / Artigas, F. / Celada, P. et al. | 2006
- 297
-
Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and miceKos, T. / Popik, P. / Pietraszek, M. / Schäfer, D. / Danysz, W. / Dravolina, O. / Blokhina, E. / Galankin, T. / Bespalov, A. Y. et al. | 2006
- 311
-
A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependenceRoozen, H. G. / de Waart, R. / van der Windt, D. A. / van den Brink, W. / de Jong, C. A. / Kerkhof, A. J. et al. | 2006
- 324
-
Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim testFarzin, D. / Mansouri, N. et al. | 2006
- 329
-
Dehydroepiandrosterone (DHEA) attenuates cocaine-seeking behavior in the self-administration model in ratsMaayan, R. / Lotan, S. / Doron, R. / Shabat-Simon, M. / Gispan-Herman, I. / Weizman, A. / Yadid, G. et al. | 2006
- 340
-
Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trialMartenyi, F. / Soldatenkova, V. et al. | 2006
- 350
-
PET neuroimaging of [11C]mirtazapine enantiomers in pigsSmith, D. F. / Marthi, K. / Munk, O. L. / Cumming, P. / Hansen, S. r. / Jakobsen, S. et al. | 2006
- 358
-
Cerebral metabolic consequences in the adult brain after neonatal excitotoxic lesions of the amygdala in ratsGerrits, M. A. / Wolterink, G. / van Ree, J. M. et al. | 2006
- 366
-
Diabetes mellitus and antipsychotic treatment in the United KingdomCarlson, C. / Hornbuckle, K. / DeLisle, F. / Kryzhanovskaya, L. / Breier, A. / Cavazzoni, P. et al. | 2006
- 376
-
The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stressNishitsuji, K. / To, H. / Shimizu, T. / Yanase, Y. / Yamada, T. / Hara, C. / Mine, K. / Higuchi, S. et al. | 2006
- 383
-
Imipramine treatment ameliorates corticosterone-induced alterations in the effects of 5-HT1A and 5-HT4 receptor activation in the CA1 area of rat hippocampusZahorodna, A. / Tokarski, K. / Hess, G. et al. | 2006
- 391
-
Dopaminergic-based pharmacotherapies for depressionPapakostas, G. I. et al. | 2006
- 403
-
AgRP(83–132) and SHU9119 differently affect activity-based anorexiaHillebrand, J. J. / Kas, M. J. / Scheurink, A. J. / van Dijk, G. / Adan, R. A. et al. | 2006
- 413
-
Increased use of mental health services related to Isotretinoin treatment: A 5-year analysisFriedman, T. / Wohl, Y. / Knobler, H. Y. / Lubin, G. / Brenner, S. / Levi, Y. / Barak, Y. et al. | 2006
- 417
-
Effects of melatonin and agomelatine in anxiety-related procedures in rats: Interaction with diazepamLoiseau, F. / Le Bihan, C. / Hamon, M. / Thiébot, M. H. et al. | 2006
- 429
-
Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individualsBarkan, T. / Peled, A. / Modai, I. / Weizman, A. / Rehavi, M. et al. | 2006
- 437
-
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction ‘knockout’Tomiyama, K. / Makihara, Y. / Yamamoto, H. / O'Sullivan, G. / Nally, R. E. / Tighe, O. / Kinsella, A. / Fienberg, A. A. / Grandy, D. K. / Sibley, D. R. et al. | 2006
- 446
-
Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive–compulsive disorder in malesDenys, D. / Van Nieuwerburgh, F. / Deforce, D. / Westenberg, H. et al. | 2006
- 451
-
Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming testConsoni, F. T. / Vital, M. A. / Andreatini, R. et al. | 2006
- 459
-
Diminished neurocardiac dynamics associated with antipsychotic-induced extrapyramidal syndromeKim, J. H. / Yi, S. H. / Park, K. T. / Ahn, Y. M. / Lee, K. Y. / Yang, S. A. / Kim, Y. S. et al. | 2006
- 464
-
From selective to highly selective SSRIs: A comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopramSchreiber, S. / Pick, C. G. et al. | 2006
- 469
-
Schizophrenia-associated neural growth factors in peripheral blood. A reviewvan Beveren, N. J. / van der Spelt, J. J. / de Haan, L. / Fekkes, D. et al. | 2006
- 481
-
Antidepressants suppress production of the Th1 cytokine interferon-γ, independent of monoamine transporter blockadeDiamond, M. / Kelly, J. P. / Connor, T. J. et al. | 2006
- 491
-
Role of nigral NFκB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in ratsSaldaña, M. / Bonastre, M. / Aguilar, E. / Marin, C. et al. | 2006
- 498
-
Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disordersYu, Y. W. / Tsai, S. J. / Liou, Y. J. / Hong, C. J. / Chen, T. J. et al. | 2006
- 504
-
Anxiety and ethanol consumption in victorious and defeated mice; effect of κ-opioid receptor activationKudryavtseva, N. / Gerrits, M. A. / Avgustinovich, D. F. / Tenditnik, M. V. / Van Ree, J. M. et al. | 2006
- 512
-
Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokersCasey, K. F. / Benkelfat, C. / Young, S. N. / Leyton, M. et al. | 2006
- 521
-
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonistsCarboni, L. / Vighini, M. / Piubelli, C. / Castelletti, L. / Milli, A. / Domenici, E. et al. | 2006
- 538
-
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmissionMicale, V. / Arezzi, A. / Rampello, L. / Drago, F. et al. | 2006
- 546
-
ECNP 2007 Award for outstanding scientists| 2006
- 547
-
Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's diseaseDeutsch, S. I. / Rosse, R. B. / Deutsch, L. H. et al. | 2006
- 552
-
Visualization of the cortical dopamine transporter in type 1 and 2 alcoholics with human whole hemisphere autoradiographyTupala, E. / Halonen, P. / Tiihonen, J. et al. | 2006
- 561
-
Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized ratsQu, Y. / Chang, L. / Klaff, J. / Seemann, R. / Greenstein, D. / Rapoport, S. I. et al. | 2006
- 572
-
Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patientsBarkan, T. / Peled, A. / Modai, I. / Barak, P. / Weizman, A. / Rehavi, M. et al. | 2006
- 580
-
Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatmentDaniel, W. A. / Haduch, A. / Syrek, M. / Boksa, J. et al. | 2006
- 588
-
Homocysteine levels in adolescent schizophrenia patientsNevo, G. A. / Meged, S. / Sela, B. A. / Hanoch-Levi, A. / Hershko, R. / Weizman, A. et al. | 2006
- 592
-
Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugsGruber, S. H. / Nomikos, G. G. / Mathé, A. A. et al. | 2006
- 601
-
The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measuresCarmody, T. J. / Rush, A. J. / Bernstein, I. / Warden, D. / Brannan, S. / Burnham, D. / Woo, A. / Trivedi, M. H. et al. | 2006
- 612
-
GABAA receptor modulation of 5-HT neuronal firing in the median raphe nucleus: Implications for the action of anxiolyticsJudge, S. J. / Young, R. L. / Gartside, S. E. et al. | 2006
- 620
-
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patientsBocchio-Chiavetto, L. / Zanardini, R. / Bortolomasi, M. / Abate, M. / Segala, M. / Giacopuzzi, M. / Riva, M. A. / Marchina, E. / Pasqualetti, P. / Perez, J. et al. | 2006
- 625
-
Author Index (Volume 16)| 2006
- 631
-
Key Word Index (Volume 16)| 2006
- 643
-
Contents of Volume 16 (2006)| 2006
- I
-
Announcement| 2006
- S1
-
Using mutational studies to determine the role of neurotransmitters in developmentLesch, K. P. et al. | 2006
- S3
-
Impact of prenatal dexamethasone on proliferation, migration and survival of cortical cellsPrzyborowska, A. / Fijal, K. / Wedzony, K. et al. | 2006
- S4
-
Fluorescence in vitro studies of human dopamine d1 and d2 receptor proteins interactionFaron-Gorecka, A. / Andrecka, J. / Dziedzicka-Wasylewska, M. / Wasylewski, Z. et al. | 2006
- S6
-
Combination of deferoxamine and lamotrigine in a rat model of hypoxic-ischemic brain damagePapazisis, G. / Kouvelas, D. / Kallaras, K. / Kaiki-Astara, A. / Guiba-Tziampiri, O. et al. | 2006
- S7
-
Correlations between serum orexins A and B and ghrelin and BMI in anorexia nervosaJanas-Kozik, M. / Krupka-Matuszczyk, I. / Krzystanek, M. et al. | 2006
- S8
-
Effect of repeated cocaine administration on the mRNAs expression of main classes of G alpha proteins in the rat brainZelek-Molik, A. / Kreiner, G. / Roman, A. / Bielawski, A. / Nalepa, I. et al. | 2006
- S10
-
Differential accumulation of cortisol and corticosterone in the murine brainMason, B. / Pariante, C. M. / Sanderson, L. / Thomas, S. A. et al. | 2006
- S11
-
GABAB receptor positive modulation attenuates selected molecular markers relevant to cocaine and nicotine dependenceLhuillier, L. / Mombereau, C. / Cryan, J. F. / Kaupmann, K. et al. | 2006
- S12
-
Identification and functional assessment of small peptides antagonists of brain-derived neurotrophic factor (BDNF)Cazorla, M. / Rose, C. / Pilon, C. / Arrang, J. M. / Sokoloff, P. et al. | 2006
- S13
-
Lithium effects on basal and stimulated CREB phosphorylation in SH-SY5Y cells: a bimodal action on CaMKIV and Erk1/2Tardito, D. / Pelizzoni, I. / Soncin, A. / Kasahara, J. / Racagni, G. / Popoli, M. et al. | 2006
- S14
-
Neural stem cell proliferation is significantly reduced in schizophrenia, but not in depression or bipolar disorderFritzen, S. / Strobel, A. / Schmitt, A. / Lesch, K. P. / Reif, A. et al. | 2006
- S15
-
Possible convergence of norepinephrine and glucocorticoids signaling pathways: relevance to depression and its treatmentYaniv, S. P. / Ben-Shachar, D. / Klein, E. et al. | 2006
- S16
-
Potential molecular interactions between the histamine H3 receptor and the dopamine D2 receptor in the rat striatumHumbert-Claude, M. / Morisset, S. / Gbahou, F. / Arrang, J. M. et al. | 2006
- S18
-
Vagus nerve stimulation increases neurotrophins gene expression and alters cell proliferation in the rat hippocampusFollesa, P. / Biggio, F. / Caria, S. / Gorini, G. / Marrosu, F. / Biggio, G. et al. | 2006
- S19
-
Biomarker discovery in cerebrospinal fluid of depressed patientsDitzen, C. / Tang, N. / Jacob, A. / Uhr, M. / Miller, C. / Turck, C. W. et al. | 2006
- S20
-
Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stressMallei, A. / Giambelli, R. / Barbiero, V. S. / Maglione, M. / Mathè / A. A. / El Khoury, A. / Carboni, L. / Domenici, E. / Racagni, G. et al. | 2006
- S21
-
Polymorphic variants in the transcriptional control region of TPH2 are preferentially transmitted in ADHDRenner, T. / Walitza, S. / Dempfle, A. / Konrad, K. / Wewetzer, C. / Halbach, A. / Herpertz-Dahlmann, B. / Remschmidt, H. / Smidt, J. / Linder, M. et al. | 2006
- S22
-
Analysis of prolyl oligopeptidase (PO) as a target for bipolar disorder — characterisation of PO null-mutant miceDi Daniel, E. / Mudge, A. S. / Maycox, P. R. et al. | 2006
- S24
-
Glucocorticoid sensitivity in whole blood cells from healthy volunteers: effect of antidepressantsOarvalho, L. / Juruena, M. F. / Papadopoulos, A. / Poon, L. / Kerwin, R. / Pariante, C. M. et al. | 2006
- S25
-
MDMA (“ECSTASY”) suppresses innate IFN-gamma production and signalling, and inhibits MHC II expression on APCsBoyle, N. T. / Connor, T. J. et al. | 2006
- S26
-
Molecular mechanisms of cannabinoid-induced neurotoxicity in rat cortical neuronsGowran, A. M. / Campbell, V. A. et al. | 2006
- S27
-
Noradrenaline stimulates production of interleukin-1 receptor antagonist in glial cells in via B2-adrenoceptor activationMcNamee, E. N. / Connor, T. J. et al. | 2006
- S28
-
Hypothalamic-pituitary-adrenocortical axis changes in male Sprague-Dawley rats after long-term voluntary exerciseDroste, S. K. / Chandramohan, Y. / Reul, J. M. et al. | 2006
- S29
-
Augmentation of antidepressant response by atypical antipsychotic drugs: electrophysiological studies in the rat brainDremencov, E. / El Mansari, M. / Blier, P. et al. | 2006
- S30
-
Inhibition of glycine uptake augments risperidone's effect on prefrontal glutamatergic transmissionKonradsson, A. / Marcus, M. M. / Hertel, P. / Svensson, T. H. / Jardemark, K. E. et al. | 2006
- S31
-
Potentiating antidepressant strategy: focus on NK1 receptor antagonistsGuiard, B. P. / Gardier, A. M. / Blier, P. et al. | 2006
- S33
-
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depressionAlboni, S. / Blom, J. M. / Corsini, D. / Benatti, C. / Capone, G. / Ferraguti, C. / Barden, N. / Tascedda, F. / Brunello, N. et al. | 2006
- S34
-
Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spinesScott, L. / Zelenin, S. / Malmersjö / S. / Kowalewski, J. M. / Zettergren-Markus, E. / Nairn, A. C. / Greengard, P. / Brismar, H. / Aperia, A. et al. | 2006
- S35
-
Genetic association data from GENDEP, a multicentre European studyHuezo-Diaz, P. / Nash, M. / Hoda, F. / Williamson, R. / McGuffin, P. / Craig, I. / Aitchison, K. J. et al. | 2006
- S37
-
Animal models of human behaviour: can they help in understanding pathology and in drug development?Rodgers, R. J. et al. | 2006
- S39
-
Long lasting effects of anti-depressants on olfactory bulbectomy induced hyperactivity in the open fieldBreuer, M. E. / Groenink, L. / Oosting, R. S. / Olivier, B. et al. | 2006
- S40
-
Strain differences in the effects of GABAA receptor subtype selective compounds in the mouse light-dark testMathiasen, L. / Mirza, N. R. / Rodgers, R. J. et al. | 2006
- S41
-
Comparative effects of PYY3–36, CCK-8S and sibutramine on food intake, feeding behaviour and weight gain in ratsHolch, P. / Rodgers, R. J. et al. | 2006
- S42
-
Behavioral and biochemical effects of single dose of desipramine are time-dependentKusmider, M. / Faron-Gorecka, A. / Dziedzicka-Wasylewska, M. et al. | 2006
- S43
-
Search for the pharmacotherapy of nicotine addiction: focus on the nicotinic receptor subtypes and cannabinoid systemZaniewska, M. / McCreary, A. C. / Filip, M. / Przegaliń / ski, E. et al. | 2006
- S45
-
On the role of serotonin 1B (5-HT1B) receptors in cocaine- or food-maintained behaviour in ratsGolda, A. / Filip, M. / Przegaliń / ski, E. et al. | 2006
- S46
-
Clozapine application in prefrontal cortex blocks the effects of systemic MK-801 on extracellular 5-HT and glutamateLó / pez-Gil, X. / Babot, Z. / Amargó / s-Bosch, M. / Suñ / ol, C. / Artigas, F. / Adell, A. et al. | 2006
- S47
-
Depression co-morbid with Alzheimer's disease: the role of stress factorsPonomareva, E. et al. | 2006
- S48
-
Effects of T3 and fluoxetine in the novelty-suppressed feeding test model of depression and anxiety: gender differencesShalom, G. / Lifschytz, T. / Lerer, B. / Newman, M. E. et al. | 2006
- S49
-
Cannabinoid modulation of impulsivity in rats: a novel pharmacotherapeutic approach for inhibitory control deficits?Pattij, T. / Janssen, M. C. / Schepers, I. / Gonzalez Cuevas, G. / Schoffelmeer, A. N. et al. | 2006
- S50
-
Increased activity of prefrontal pyramidal neurons after phencyclidine administration: reversal by clozapineKargieman, L. / Celada, P. / Artigas, F. et al. | 2006
- S51
-
Studying the neural changes underlying the transition from casual to compulsive drug useRijkens, M. M. / Vanderschuren, L. J. et al. | 2006
- S53
-
The anxiolytic effect of CRF in rat brain frontal cortex is prevented by CRF1&2 receptor antagonistsZieba, B. / Uchacz, T. / Domin, H. / Branski, P. / Smialowska, M. / Pilc, A. et al. | 2006
- S54
-
Abnormal social cognitive processing in 47, XXY men: implications for the study of schizophreniavan Rijn, S. / Swaab, H. / Aleman, A. / Jellema, T. / Kahn, R. S. et al. | 2006
- S55
-
Cannabinoid CB1 receptor blocakade affects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptideMazzola, C. / Micale, V. / Leggio, G. M. / Drago, F. et al. | 2006
- S56
-
Effect of lithium on the deficit in performance of a reversal learning task induced by phencyclidine in the ratIdris, N. / Grayson, B. / Neill, J. C. et al. | 2006
- S58
-
The effect of neurotrophin receptor expression and signalling on recognition learning in the ratHennigan, A. / Kelly, A. et al. | 2006
- S59
-
Age and strain-related differences in sensory-motor abilities in different mouse strainsDeiana, S. / Harrington, C. / Riedel, G. et al. | 2006
- S61
-
Behavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stressLeggio, G. M. / Micale, V. / Consoli, D. / Mazzola, C. / Drago, F. et al. | 2006
- S62
-
The role of medial septal NMDA receptors in behavioral functions of the hippocampus in the ratElvander Tottie, E. / Eriksson, T. / Johansson, B. / Sandin, J. / gren, S. O. et al. | 2006
- S65
-
The pre-synaptic dopaminergic system before and after the onset of psychosis: initial resultsHowes, O. D. / Montgomery, S. A. / Asselin, M. / Murray, R. M. / McGuire, P. K. / Grasby, P. et al. | 2006
- S66
-
Changes in benzodiazepine receptor binding in Dutch veterans with posttraumatic stress disorderGeuze, E. / van Berckel, B. N. / Boellaard, R. / Windhorst, B. D. / Luurtsema, G. / Lammertsma, A. A. / Vermetten, E. / Westenberg, H. G. et al. | 2006
- S67
-
Association study of a functional cathechol-O-methyltransferase polymorphism and cognitive remediation in schizophreniaBosia, M. / Cavallaro, R. / Anselmetti, S. / Bechi, M. / Cocchi, F. / Poletti, S. / Marino, E. et al. | 2006
- S68
-
Cannabis use increases body mass index in patients with psychosisMondelli, V. / Di Forti, M. / Saeedzadeh-Sardahaee, F. / Butt, A. / Miorelli, A. / Mule, A. / Gafoor, R. / Dazzan, P. / Murray, R. M. / Pariante, C. M. et al. | 2006
- S70
-
Influence of serotonin transporter promoter polymorphism on brain activation during a moral valence decision taskRadaelli, D. / Bernasconi, A. / Benedetti, F. / Blasi, V. / Colombo, C. / Falini, A. / Scotti, G. / Smeraldi, E. et al. | 2006
- S71
-
Is controversial efficacy of SSRI in treating depression in child and adolescent related to differences in study design?Usala, T. / Clavenna, A. / Bonati, M. / Zuddas, A. et al. | 2006
- S72
-
Long term outcome of drug-resistant bipolar depression: a 9 months prospective follow-up after chronotherapeuticsPontiggia, A. / Benedetti, F. / Barbini, B. / Cigala Fulgosi, M. / Colombo, C. / Dallaspezia, S. / Smeraldi, E. et al. | 2006
- S73
-
Predictive parameters for methylphenidate use and compliance in children with attention deficit hyperactivity disorderAtzori, P. / Ancilletta, B. / Usala, T. / Danjou, F. / Zuddas, A. et al. | 2006
- S74
-
Divalproex sodium vs. placebo for the treatment of child and adolescent autismAnagnostou, E. / Soorya, L. / Swanson, E. / Rusoff, J. / Chaplin, W. / Wasserman, S. / Hollander, E. et al. | 2006
- S78
-
Progressive brain volume changes in first-episode psychosis: a five-year follow-up studyRais, M. / Cahn, W. / van Haren, N. E. / Hulshoff Pol, H. E. / Caspers, E. / Schnack, H. G. / Kahn, R. S. et al. | 2006
- S79
-
Single or low dose of ecstasy, is it safe? A prospective study on neurotoxicity of ecstasy in new ecstasy usersde Win, M. M. / Jager, G. / Reneman, L. / Lavini, C. / van den Brink, W. / den Heeten, G. J. et al. | 2006
- S80
-
Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy usersJager, G. / de Win, M. M. / van der Tweel, I. / Kahn, R. S. / van Ree, J. M. / van den Brink, W. / Ramsey, N. F. et al. | 2006
- S81
-
The effects of exertion and high levels of lactate in a 35% CO2 challenge in patients with panic disorderEsquivel, G. / Berlanga-Cisneros, C. / Lara-Muñ / oz, C. / Griez, E. et al. | 2006
- S82
-
An open-label trial of escitalopram in the treatment of impulsive-compulsive internet usage disorderDell' Osso, B. / Altamura, A. C. / Hadley, S. J. / Baker, B. R. / Hollander, E. et al. | 2006
- S86
-
Anxiolytic-like effects of group III mGluR positive modulator PHCCC and agonist ACPT-I injected to the rat hippocampusStachowicz, K. / Chojnacka-Wó / jcik, E. / Klak, K. / Pilc, A. et al. | 2006
- S87
-
Benzodiazepines vs. combination of benzodiazepines and SSRI in treatment of panic disorder with agoraphobiaLatas, M. et al. | 2006
- S89
-
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opioid receptor agonistVergura, R. / Balboni, G. / Spagnolo, B. / Gavioli, E. C. / Lambert, D. G. / McDonald, J. / Trapella, C. / Regoli, D. / Salvadori, S. / Calo, G. et al. | 2006
- S90
-
In search of the anxiolytic effects of nicotinic receptor ligandsKrawczyk, M. / Popik, P. et al. | 2006
- S91
-
Molecular dissection of the role of GABAB1 receptor isoforms 1a and 1b in anxiety-related behaviourJacobson, L. H. / Neijt, H. C. / Bettler, B. / Kaupmann, K. / Cryan, J. F. et al. | 2006
- S92
-
Anxiety as a consequence of hypokinesia and its correction by afobazoleAshrafyan, K. / Balasanyan, M. et al. | 2006
- S95
-
Author index| 2006
- S99
-
Keyword index| 2006
- S101
-
Generalized anxiety disorder: What are we missing?Allgulander, C. et al. | 2006
- S109
-
Generalized anxiety disorder: A comorbid diseaseNutt, D. / Argyropoulos, S. / Hood, S. / Potokar, J. et al. | 2006
- S119
-
Therapeutic options: Addressing the current dilemmaDinan, T. et al. | 2006
- S128
-
Pregabalin: From molecule to medicineKavoussi, R. et al. | 2006
- S135
-
Optimisation of long-term treatment in schizophrenia: Treating the true spectrum of symptomsKasper, S. et al. | 2006
- S142
-
Long-term health considerations in schizophrenia: Metabolic effects and the role of abdominal adiposityVan Gaal, L. F. et al. | 2006
- S149
-
Differential metabolic effects of antipsychotic treatmentsHaupt, D. W. et al. | 2006
- S156
-
Meeting everyday challenges: Antipsychotic therapy in the real worldGorwood, P. et al. | 2006
- S165
-
S.01.04 Psycho-education in management of schizophreniaHoschl1, C. / Motlova, L. et al. | 2006
- S166
-
S.02.02 Abnormal development of brain function in ADHD and effects of methylphenidateRubia, K. / Halari, R. / Smith, A. B. / Mohammad, M. / Taylor, E. et al. | 2006
- S167
-
S.02.05 Neurocognitive effects of methylphenidate in adult attention deficit/hyperactivity disorderBekker, E. M. / Verster, J. C. / Kenemans, J. L. et al. | 2006
- S168
-
S.03.03 mRNA expression in post-mortem studiesGarcia-Sevilla, J. A. / Arteta, D. / Meana, J. J. et al. | 2006
- S169
-
S.04.01 Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stressMallei, A. / Giambelli, R. / Barbiero, V. S. / Mathe, A. A. / El Khoury, A. / Carboni, L. / Domenici, E. / Aitchison, K. J. / Racagni, G. / Popoli, M. et al. | 2006
- S170
-
S.04.04 Abnormalities in behaviour and reduction in expression of specific hippocampal genes genes by prenatal stress in female offspring are reversed by neonatal handlingNachum-Biala, Y. / Salomon, S. / Bogosh, Y. / Linial, M. / Weinstock, M. et al. | 2006
- S171
-
S.04.06 Fluorescence in vitro studies of human dopamine D1 and D2 receptor proteins interactionFaron-Gorecka, A. / Andrecka, J. / Dziedzicka-Wasylewska, M. / Wasylewski, Z. et al. | 2006
- S173
-
S.05.04 Steroid hormone treatmentsWolkowitz, O. M. / Reus, V. I. / Epel, E. / Mellon, S. et al. | 2006
- S175
-
S.07.03 RIC-3, an effector of nAChR activity: structure, function, quantity, and regulationBiala, Y. / Treinin, M. et al. | 2006
- S176
-
S.07.06 Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy usersJager, G. / De Win, M. M. / Kahn, R. S. / Van Ree, J. M. / Van den Brink, W. / Ramsey, N. F. et al. | 2006
- S177
-
S.07.08 Is controversial efficacy of SSRI in treating depression in child and adolescent related to differences in study design?Usala, T. / Clavenna, A. / Bonati, M. / Zuddas, A. et al. | 2006
- S178
-
S.08.03 D2 antagonist/5-HT1A agonist interactionsNewman-Tancredi, A. et al. | 2006
- S179
-
S.09.01 Bipolar spectrum disorder: relapse and remissionJudd, L. et al. | 2006
- S180
-
S.09.04 New antiepileptics in bipolar mixed statesPerugi, G. et al. | 2006
- S181
-
S.10.03 Neuroimaging .ndings in pathological gamblingBuchel, C. et al. | 2006
- S182
-
S.11.01 Common pathological pathways in neurodegenerative brain diseases: the genes involved in Parkinsons diseaseBrice, A. et al. | 2006
- S183
-
S.11.05 Growth factors in the treatment of neurodegenerative diseasesSaarma, M. et al. | 2006
- S184
-
S.14.04 CATIE trial resultsLieberman, J. A. / Stroup, T. S. / McEvoy, J. P. / Swartz, M. S. / Keefe, R. / Perkins, D. O. / Davis, S. / Davis, C. E. / Lebowitz, B. / Hsiao, J. et al. | 2006
- S187
-
S.16.03 Chronic fatigue syndromeKerr, J. R. / Petty, R. / Burke, B. / Fear, D. / Montgomery, J. / Richards, S. C. / Thomas, M. / Smith, A. P. / Harrison, T. J. / Kellam, P. et al. | 2006
- S188
-
S.17.01 Pharmacological management of .rst episode adolescent psychosisFegert, J. / Libal, G. / Plener, P. et al. | 2006
- S189
-
S.17.04 Pharmacological treatment of adolescent depressionCohen, D. et al. | 2006
- S191
-
S.19.01 Psychoses converge via D2high receptorsSeeman, P. et al. | 2006
- S192
-
S.19.04 In vivo imaging of the D2high receptors occupancy by antipsychotics in SchizophreniaGraff, A. / Mamo, D. / Kapur, S. et al. | 2006
- S193
-
S.20.02 Neuroendocrine controls of sleepSteiger, A. / Kimura, M. / Kluge, M. / Schussler, P. et al. | 2006
- S194
-
S.20.05 Genetic aspects of sleepTafti, M. et al. | 2006
- S195
-
S.21.05 The beta-3-adrenergic receptor in anxiety disorders and their treatmentStemmelin, J. / Cohen, C. / Griebel, G. et al. | 2006
- S196
-
S.22.05 Very early onset schizophreniaRapoport, J. et al. | 2006
- S197
-
S.23.03 Neuroimaging in Alzheimers diseaseFox, N. C. et al. | 2006
- S198
-
S.24.03 Role of extrasynaptic GABA in hippocampusOrser, B. A. / Martin, L. J. / Cheng, V. Y. / Bonin, R. P. et al. | 2006
- S200
-
S.25.03 Smoking cessation treatment in patients with depression: outcomes, relapse vulnerability factors, and targeted inventionsHitsman, B. et al. | 2006
- S201
-
S.26.01 Neurotransmitter genes in causation and treatment responseGorwood, P. / Hamdani, N. / Dubertret, C. / Boni, C. et al. | 2006
- S202
-
S.27.02 Social isolation and brain functionMarsden, C. / Bianchi, M. / Pardon, M. C. / Porkess, V. / Fone, K. C. et al. | 2006
- S203
-
S.28.02 Influence of variants of TPH2 on the regulation of the central serotonin systemCaron, M. G. / Zhang, X. / Beaulieu, J. M. / Gainetdinov, R. R. / Sotnikova, T. et al. | 2006
- S205
-
E.04.01 Diagnosis and assessmentof adult ADHDBuitelaar, J. K. et al. | 2006
- S206
-
E.06.01 Gender differences: focus on addictionFischer, G. / Ebner, N. / Winklbaur, B. / Thau, K. et al. | 2006
- S209
-
P.1.a.002 Protective effect of haplotype of dysbindin gene (DTNBP1) on chromosome 6p22.3 to major depressive disorderKim, J. J. / Pae, C. U. / Kim, T. S. / Lee, C. U. / Lee, S. J. / Lee, C. / Jun, T. Y. / Paik, I. H. et al. | 2006
- S210
-
P.1.a.005 Association studies of the CT repeat polymorphism in the cholecystokinin B receptor gene with the diagnosis and the response of pharmacotherapy in Korean patients with panic disorderKim, W. et al. | 2006
- S211
-
P.1.a.007 Retinoid function related genes do not cause psychosis in a large inbred familyOzer, S. / Akyn, B. / Ulusahin, A. / Akarsu, N. et al. | 2006
- S213
-
P.1.a.010 The C270T and Val66Met polymorphisms of brain-derived neurotrophic factor in schizophreniaJuhasz, A. / Rimanoczy, A. / Keri, S. / Cimmer, C. / Szekeres, G. / Szendi, I. / Janka, Z. et al. | 2006
- S214
-
P.1.a.012 Transcripts expression profile of the genes assayed with the oligonucleotide microarray technique in young women with anorexia nervosaJanas-Kozik, K. M. / Stachowicz, S. M. / Krupka-Matuszczyk, K. M. / Mazurek, M. U. et al. | 2006
- S215
-
P.1.a.014 Expressed gene differences on .uoxetine treatment in rat hippocampusPaik, K. C. / Choi, J. H. / Han, C. H. et al. | 2006
- S216
-
P.1.a.015 Strain differences in susceptibility to unpredictable chronic mild stress as assessed by hippocampal gene expression profilingPaya-Cano, J. L. / Sluyter, F. / Mineur, Y. S. / Fernandes, C. / Crusio, W. E. / Schalkwyk, L. C. et al. | 2006
- S217
-
P.1.b.001 Registration of multiunit activity and analysis of neuro-neuronal, cardio-neuronal and respiratory-neuronal temporal relationshipsPrudnikau, H. et al. | 2006
- S218
-
P.1.b.003 Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias?Fallgatter, A. J. / Polak, T. / Metzger, F. / Plichta, M. M. / Ringel, T. / Ehlis, A. C. et al. | 2006
- S219
-
P.1.b.005 Elevation of histamine H1 receptor mRNA level in hypothalamus of starved ratsFukui, H. et al. | 2006
- S220
-
P.1.b.007 Heart rate variability in patients with anxiety disordersDragasek, J. / Drimalova, M. / Durdik, P. / Migra, M. / Holla, G. et al. | 2006
- S221
-
P.1.b.009 Neural stem cell proliferation is significantly reduced in schizophrenia, but not in affective psychosesReif, A. / Fritzen, S. / Finger, M. / Strobel, A. / Schmitt, A. / Lesch, K. P. et al. | 2006
- S222
-
P.1.b.011 The differences of electroencephalogram coherence between schizophrenia and bipolar disorderPark, J. W. / Hong, K. S. / Park, S. D. / Lee, Y. S. et al. | 2006
- S224
-
P.1.c.002 Influence of nootropil on neuroplasticity of the brain cortex in conditions of hypokinesiaMelkonyan, K. et al. | 2006
- S225
-
P.1.c.004 Different Salvia species as ligands for selected central nervous system receptors: in vitro binding experimentsCavallo, F. / Nencini, C. / Capasso, A. / Bruni, G. / Micheli, L. et al. | 2006
- S226
-
P.1.c.006 Modification of formalin-induced nociception by different histamine receptor agonists and antagonistsFarzin, D. / Mansouri, N. et al. | 2006
- S227
-
P.1.c.008 The effects of venlafaxine on neurites growth of PC12 cellsLee, J. N. / Yang, B. H. et al. | 2006
- S228
-
P.1.c.010 From selective to highly selective SSRIs: the antinociceptive properties of four serotonergic antidepressantsSchreiber, S. / Pick, C. G. et al. | 2006
- S229
-
P.1.c.012 Anti-aversive effect of acute clomipramine and .uoxetine on fear-induced behaviour elicited by preys in confront with rattlesnakesElias-Filho, D. H. / Ubiali, W. A. / Coimbra, N. C. et al. | 2006
- S231
-
P.1.c.015 The role of voltage dependent sodium channels on the antidepressant-like effect of lamotrigineCodagnone, F. T. / Consoni, F. T. / Rodrigues, A. L. / Vital, M. A. / Andreatini, R. et al. | 2006
- S232
-
P.1.c.017 F15599, a highly selective serotonin 5-HT1A receptor agonist: in vitro affinity and efficacy profile at native rat and recombinant human 5-HT1A receptorsNewman-Tancredi, A. / Assie, M. B. / Cosi, C. / Bruins Slot, L. / Cussac, D. / Martel, J. C. et al. | 2006
- S234
-
P.1.c.020 Regulation of cytochrome P-450 activity by the brain dopaminergic systemWojcikowski, J. / Golembiowska, K. / Danie, W. A. et al. | 2006
- S235
-
P.1.c.022 Effects of prenatal exposure to nitric oxide synthase inhibitor on MK-801-elicited behavioural sensitivity in postnatal juvenile ratsPark, S. H. / Kim, G. J. / Chung, Y. I. et al. | 2006
- S236
-
P.1.c.024 Effects of haloperidol on intracellular calcium ion change in hamster insulinoma cellsKim, M. H. / Shin, J. H. / Park, K. C. / Park, G. S. / Gong, I. D. / Kim, T. H. et al. | 2006
- S237
-
P.1.c.026 a-1 Adrenergic receptors stimulation induces the proliferation of neural progenitor cellsHiramoto, T. / Watanabe, Y. et al. | 2006
- S238
-
P.1.c.027 Comparative efficacy of liposome-entrapped amiloride and free amiloride in animal models of seizures and serum potassium in miceAli, A. / Pillai, K. K. / Ahmad, F. J. / Vohora, D. et al. | 2006
- S239
-
P.1.c.030 Antidepressant treatment reduces fos-like immunoreactivity in different regions of periaqueductal gray matterOliveira, R. M. / Lino-de-Oliveira, C. / Carobrez, A. P. / De Lima, T. C. / Del Bel, E. A. / Guimaraes, F. S. et al. | 2006
- S240
-
P.1.c.032 Regulation of NA and GABA systems on DOI (agonist 5-HT2A/2C) anxiolytic-like effect in the four-plate test and cerebral localization of target receptorsMasse, F. / Hascoet, M. / Bourin, M. et al. | 2006
- S242
-
P.1.c.035 Gabapentin and topiramate protect rat neurons against staurosporine induced apoptosisAbramovici, S. / Bajenaru, O. / Popescu, B. O. et al. | 2006
- S243
-
P.1.c.037 Mitochondria as the memantine targetShevtsova, E. P. / Dubova, L. G. / Kireeva, E. G. / Bachurin, S. O. et al. | 2006
- S244
-
P.1.c.039 Effects of aripiprazole on dopamine and 5-HT function in rabbit brainKawamura, T. et al. | 2006
- S245
-
P.1.c.041 Fluorescence in vitro studies of human adenosine A2A and serotonin 5HT1A receptors homodimerizationLukasiewicz, S. / Blasiak, E. / Faron-Gorecka, A. / Wasylewski, Z. / Dziedzicka-Wasylewska, M. et al. | 2006
- S246
-
P.1.c.043 The effects of risperidone, olanzapine and haloperidol on enzyme activities in kidney tissue of ratsGulaboglu, M. / Halici, Z. / Aydin, N. / Cadirci, E. / Gul, M. / Suleyman, H. / Oral, E. et al. | 2006
- S247
-
P.1.c.045 The effects of risperidone, olanzapine and haloperidol on enzyme activities in erythrocytes and plasma of ratsHalici, Z. / Ozabacigil, F. / Aydin, N. / Gulaboglu, M. / Gul, M. / Suleyman, H. et al. | 2006
- S248
-
P.1.c.047 A double-blind, placebo-controlled investigation of the anxiolytic effects of XBD173 (AC-5216) and alprazolam using a CCK-4-induced panic challengeRupprecht, R. / Eser, D. / Schuele, C. / Kucher, K. / Merz, M. / Krebs-Brown, A. / Floesser, A. / Lataste, X. / Bruenig-Traebert, I. / Zaninelli, R. et al. | 2006
- S249
-
P.1.c.049 Descending serotonergic pathways play an inhibitory or facilitatory role in spinal pain processing by 5-HT7 or 5-HT3 receptors in acute and chronic painDogrul, A. / Ossipov, M. / Lai, J. / Porreca, F. et al. | 2006
- S250
-
P.1.d.002 Aggressive and hyperactive behavioural characteristics is increased in maternal social separated ratKwak, H. R. / Park, J. I. / Ko, H. J. / Kim, S. J. / Choi, Y. S. / Lee, H. J. et al. | 2006
- S251
-
P.1.d.004 Effects of a selective and brain penetrating 5-HT6 receptor antagonist in animal models of depression and anxietyWesolowska, A. / Nikiforuk, A. / Stachowicz, K. / Chojnacka-Wojcik, E. et al. | 2006
- S252
-
P.1.d.006 Behavioral phenotyping of sodium-myo-inositol cotransporter knockout mice with reduced brain inositolBersudsky, Y. / Shaldubina, A. / Johanson, R. / Buccafusca, R. / Agam, G. / Belmaker, R. H. / Berry, G. et al. | 2006
- S253
-
P.1.d.008 Alterations in the functional activity of the prodynorphin gene expression in selected brain regions are associated to increased preference for ethanol and the development of dependenceOliva, J. M. / Lorente, A. / Sanguino, E. / Manzanares, J. et al. | 2006
- S254
-
P.1.d.010 A dopaminergic mechanism recruited in the anti-punitive effect of the DOI in the four-plates test-retest paradigmRipoll, N. / Hascoet, M. / Bourin, M. et al. | 2006
- S255
-
P.1.d.011 Anxiolytic-like effects of NMDA-receptor antagonist injected into the ventral but not dorsal hippocampus in rats submitted to the elevated plus mazeHackl, L. P. / Carobrez, A. P. et al. | 2006
- S256
-
P.1.d.013 Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonistMicale, V. / Leggio, G. M. / Mazzola, C. / Tamburella, A. / Drago, F. et al. | 2006
- S257
-
P.1.d.015 Nociceptin and [Nphe1, Arg14, Lys 15]-nociceptin-NH2, UFP-101 restored opioid antinociception in morphine tolerant micePieretti, S. / Di Giannuario, A. et al. | 2006
- S258
-
P.1.d.017 Participation of the ventral hippocampus in the modulation of anxiety: role of nitric oxide, Rizzi A., et al., in the 2002, Br. behaviour of J. Pharmacol, 136, rats evaluated in the 303-311. elevated T-mazeCalixto, A. V. / Faria, M. S. / De Lima, T. C. et al. | 2006
- S259
-
P.1.e.001 Fusiform gyral volumes over two time points in adolescent-onset schizophreniaJames, A. / James, S. M. / Smith, D. M. / Day, C. et al. | 2006
- S261
-
P.1.e.006 Using a contextual binding task as a probe to explore hippocampal activation in schizophrenia: fMRI studiesBoulay, L. J. / Phillips, J. L. / Boyer, P. et al. | 2006
- S263
-
P.1.e.009 Low-resolution electromagnetic tomography (LORETA) source imaging compared with structural brain imaging in patients having organic brain lesionLee, S. H. / Kwon, G. H. / Park, Y. M. / Kim, H. / Lee, K. J. / Chung, Y. C. et al. | 2006
- S264
-
P.1.e.011 Effect of the acute tryptophan depletion on the neural response to happy and sad facesFusar Poli, P. / Allen, P. / Lee, F. / Surguladze, S. / Tunstall, N. / Fu, C. / Brammer, M. / Cleare, A. / McGuire, P. et al. | 2006
- S265
-
P.1.e.013 No differences in the ratio of dopamine transporter availability of putamen and caudate nucleus between patients with combined and with inattentive type of ADHDKrause, K. H. / La Fougere, C. / Krause, J. / Ackenheil, M. / Dresel, S. et al. | 2006
- S267
-
P.1.e.016 Intersubject differences in reappraisal strategies of negative emotion: a functional MRI studyViviani, R. / Ehrhard, K. / Lo, H. / Horn, A. B. et al. | 2006
- S268
-
P.1.e.018 Action monitoring and psychotic ego-disturbances: a functional MRI model to link selected psychopathologic symptoms to regional physiological dysfunctionsSchnell, K. / Heekeren, K. / Daumann, J. / Schnell, T. / Neukirch, A. / Moller-Hartmann2, W. / Heelmann, V. / Gouzoulis-Mayfrank, E. et al. | 2006
- S269
-
P.1.e.019 Reduction of prefrontal gray matter volume in first-episode schizophrenia independent of risperidone treatmentKasparek, T. / Prikryl, R. / Schwarz, D. / Kucerova, H. / Mikl, M. / Ceskova, E. / Krupa, P. et al. | 2006
- S270
-
P.1.e.021 Neural correlates of emotional self in bipolar disorder: a BOLD functional MRI 3 T studyRadaelli, D. / Benedetti, F. / Bernasconi, A. / Blasi, V. / Cadioli, M. / Colombo, C. / Dallaspezia, S. / Falini, A. / Scotti, G. / Smeraldi, E. et al. | 2006
- S271
-
P.1.e.023 Functional MRI investigation using visual and emotional memory induction paradigms in chronic depressionRavindran, A. V. / Smith, A. / Cameron, C. / Bhatla, R. / Cameron, I. et al. | 2006
- S273
-
P.1.e.026 A 3 T BOLD functional MRI study of the neural underpinnings of depressionBernasconi, A. / Benedetti, F. / Blasi, V. / Cadioli, M. / Colombo, C. / Dallaspezia, S. / Falini, A. / Radaelli, D. / Scotti, G. et al. | 2006
- S274
-
P.1.f.001 Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I studyCollie, A. / Darekar, A. / Maruff, P. / Snyder, P. / Huggins, J. P. et al. | 2006
- S275
-
P.1.f.004 Neurocognitive function in patient with Hwa-byung and major depressive disorderChoi, J. H. / Lee, S. H. / Yun, Y. H. / Han, C. H. et al. | 2006
- S276
-
P.1.f.006 High frequency repetitive TMS over the right dorsolateral prefrontal cortex: influence on Stroop task performanceVanderhasselt, M. A. / De Raedt, R. / Baeken, C. / Clerinx, P. / Leyman, L. / Dhaenen, H. et al. | 2006
- S280
-
P.1.g.001 Increased CSF cholecystokinin, NPY and GABA levels in pathological gamblingNordin, C. / Sjodin, I. et al. | 2006
- S281
-
P.1.g.003 Two cases of the induction of EEG seizure during long-term rapid-rate TMSZyss, T. / Zieba, A. / Dudek, D. / Sawicki, B. / Krawczyk, A. / Siwek, M. et al. | 2006
- S283
-
P.2.a.002 A geriatric depression scale detects depression in Hong Kong Chinese elderly patients with pneumoconiosis?Tang, W. K. / Lum, C. M. / Ungvari, G. S. / Chiu, H. F. et al. | 2006
- S284
-
P.2.a.003 Treatment resistant depression: response to prednisolone supression testJuruena, M. F. / Papadopoulos, A. S. / Poon, L. / Lightman, S. / Cleare, A. J. / Pariante, C. M. et al. | 2006
- S285
-
P.2.a.005 Severe depression without ICD-10 somatic syndrome does exist: clinical characteristics and diagnostic efficiency of somatic symptomsThuile, J. / Even, C. / Rouillon, F. / Guelfi, J. D. et al. | 2006
- S286
-
P.2.a.007 "Difficult depression" at private psychiatric clinics throughout France: an epidemiological survey (DEDICACE survey)Bougerol, T. / Gerard, A. / Bouhours, P. / Moreau-Mallet, V. et al. | 2006
- S287
-
P.2.a.009 Natural killer T cell patients with major depressive disorderJeon, Y. W. / Han, S. I. / Park, E. J. et al. | 2006
- S288
-
P.2.a.011 A systematic review and meta-analysis on the efficacy of brief psychotherapies and pharmacotherapy in the acute treatment of depressionBallesteros, J. / Goemes, I. / Gonzalez-Pinto, M. A. / Rueda, J. R. / Querejeta, I. / Retolaza, A. et al. | 2006
- S290
-
P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled studyMichelson, D. / Adler, L. A. / Amsterdam, J. D. / Dunner, D. L. / Nierenberg, A. A. / Reimherr, F. W. / Schatzberg, A. F. / Kelsey, D. K. / Feldman, P. D. / Levine, L. R. et al. | 2006
- S291
-
P.2.a.016 Depression in Chinese patients with Parkinsons and clinical determinantsTang, W. K. / Chan, D. M. / Chiu, H. F. / Ungvari, G. S. / Wong, K. S. / Mok, V. et al. | 2006
- S292
-
P.2.a.018 Bupropion efficacy in major depressive disorder and alcohol dependence dual diagnosisVasile, D. / Sarmache, M. / Vasile, M. L. / Gheorghe, M. D. et al. | 2006
- S293
-
P.2.a.020 High cholesterol, triglycerides, and body-mass index in suicide attempters: a population-based studyBrunner, J. / Bronisch, T. / Pfister, H. / Jacobi, F. / Hoefler, M. / Wittchen, H. U. et al. | 2006
- S294
-
P.2.a.021 Depression and socio-economic status: an 8-year longitudinal population-based studyLorant, V. / Croux, C. / Weich, S. / Deliege, D. / Mackenbach, J. / Ansseau, M. et al. | 2006
- S295
-
P.2.a.023 Maternal suicidality and risk of suicidality in offspring: findings from a community studyLieb, R. / Bronisch, T. / Hoefler, M. / Schreier, A. / Wittchen, H. U. et al. | 2006
- S296
-
P.2.a.025 Predictors of response to vagus nerve stimulationBrodesser, D. / Frick, C. / Hosten, S. / Axmacher, N. / Kosel, M. / Kuehn, K. U. / Brannan, S. / Maier, W. / Schlaepfer, T. E. et al. | 2006
- S297
-
P.2.a.028 Mania, hypomania, and suicidality: findings from a prospective community studyBronisch, T. / Schwender, L. / Hoefler, M. / Wittchen, H. U. / Lieb, R. et al. | 2006
- S298
-
P.2.a.030 Fatigue correlates in major depression: preliminary findingsFerentinos, P. P. / Kontaxakis, V. P. / Havaki-Kontaxaki, B. J. / Dikeos, D. G. / Soldatos, C. R. et al. | 2006
- S299
-
P.2.a.031 Serotonin transporter promoter genetic characterization: possible pharmacogenetic implications of rare allelesPirovano, A. / Lorenzi, C. / Aartioli, P. / Marino, E. / Catalano, M. / Smeraldi, E. et al. | 2006
- S300
-
P.2.a.034 RAPSODY registry of patients with painful symptoms and observation of depression and anxietyMignon, A. / Linkowski, P. / Van Heeringen, C. / Dramaix, M. / Leyman, S. et al. | 2006
- S302
-
P.2.b.002 Depressive-like phenotype in mice lacking cannabinoid CB1 receptorsValverde, O. / Aso, E. / Ozaita, A. / Valdizan, E. / Pazos, A. / Maldonado, R. et al. | 2006
- S303
-
P.2.b.004 Functional activity of a2-adrenoceptors in postmortem frontal cortex of depressed suicide victimsDiez-Alarcia, R. / Valdizan, E. M. / Gonzalez-Maeso, J. / Garcia-Sevilla, J. A. / Pazos, A. / Meana, J. J. et al. | 2006
- S304
-
P.2.b.006 Allosteric modulation of GABAB receptor coupling in rat brain: G-protein subtype dependence revealed by immunocapture scintillation proximity assaysMannoury La Cour, C. / Herbelles, C. / Millan, M. J. et al. | 2006
- S305
-
P.2.b.008 Antidepressant-like activity of Wf-516, an antagonist of 5-HT1A receptors and inhibitor of 5-HT reuptake, in a chronic mild stress model of depression in ratPapp, M. / Gruca, P. / Litwa, E. / Lason, M. / Przegalinski, E. et al. | 2006
- S306
-
P.2.b.010 Oxytocin, vasopression and anxiety in major depression: ago-antagonist neurohormonesScantamburlo, G. / Hansenne, M. / Fuchs, S. / Pitchot, W. / Reggers, J. / Marechal, P. / Pinto, E. / Ansseau, M. / Legros, J. J. et al. | 2006
- S307
-
P.2.b.011 Copper as trait marker of major depressive episodeFontana, M. / Squitti, R. / Cesaretti, S. / Bevacqua, M. G. / Ventriglia, M. / Ribolsi, M. / Zuppi, P. L. / Rossini, P. M. et al. | 2006
- S308
-
P.2.b.013 Neuropeptides in human cerebrospinal fluid and in brains of animal models of depression - effects of treatmentMathe, A. A. / Nikisch, G. / Agren, H. / Baumann, P. / El Khoury, A. / Gruber, S. H. / Husum, H. / Jimenez-Vasquez, P. / Wortwein, G. / Andersson, W. et al. | 2006
- S309
-
P.2.b.015 The infralimbic cortex modulates stress-induced coping behaviour - implications for depressionSlattery, D. A. / Cryan, J. F. et al. | 2006
- S310
-
P.2.b.017 Biologic epistasis between SERT and BDNF: complex genetic mechanisms of depressionPezawas, L. P. / Goldman, A. L. / Verchinski, B. A. / Mattay, V. A. / Callicott, J. H. / Kolachana, B. S. / Straub, R. E. / Egan, M. F. / Meyer-Lindenberg, A. / Weinberger, D. R. et al. | 2006
- S311
-
P.2.b.019 Behavioural characterization of mice knockout for the nociceptin/orphanin FQ receptor gene in animal models of anxietyGavioli, E. C. / Marzola, G. / Calo, G. et al. | 2006
- S313
-
P.2.c.002 Efficacy of milnacipran augmentation of nicotine replacement therapy on post-cessation mood and anxiety in smokers with previous history of major depressionBerlin, I. / Aubin, H. J. / Mansuy, L. / Lagrue, G. et al. | 2006
- S314
-
P.2.c.004 Changes in sexual functions under mirtazapine treatment - primary data of a national, multicentre, prospective observational study in depressed patientsOsvath, P. / Fekete, S. / Voros, V. / Almasi, J. et al. | 2006
- S315
-
P.2.c.006 Efficacy and safety of bupropion extended release in elderly patients with major depressive disorderChrzanowski, W. / Rousseau, R. / Hewett, K. / Gee, M. D. / Wightman, D. / Richard, N. E. / Modell, J. G. / Goodale, E. P. et al. | 2006
- S316
-
P.2.c.008 Is it appropriate to combine conceptually related scores in meta-analyses? - A Monte Carlo simulation approach for antidepressant trialsBallesteros, J. / Guemes, I. et al. | 2006
- S317
-
P.2.c.010 Impact of the melatonergic antidepressant agomelatine on sleep-wake rhythms of depressed patientsGuilleminault, C. / Quera-Salva, M. A. et al. | 2006
- S319
-
P.2.c.013 Antidepressant efficacy of agomelatine 25-50 mg versus venlafaxine 75 -150 mg: two randomized, double blind studiesKennedy, S. H. / Guilleminault, C. et al. | 2006
- S320
-
P.2.c.015 Effect of mirtazapine for insomnia in patients with major depressive episode: a polysomnographic studyKim, H. / Lee, K. J. / Lee, S. H. et al. | 2006
- S321
-
P.2.c.017 Antidepressant efficacy of agomelatine in major depressive disorder:meta-analysis of three pivotal studiesMontgomery, S. A. / Olie, J. P. / Kennedy, S. H. et al. | 2006
- S322
-
P.2.c.019 Two-year maintenance treatment study assessing recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depressionKeller, M. / Yan, B. / Dunner, D. / Ferguson, J. / Friedman, E. / Gelenberg, A. / Hirschfeld, R. M. / Kocsis, J. / Kornstein, S. / Nemeroff, C. et al. | 2006
- S323
-
P.2.c.020 The efficacy of the oestrogen substitution associated with antidepressants in the treatment of menopausal depressionDan, I. A. / Grimberg, M. et al. | 2006
- S324
-
P.2.c.022 Mirtazapine versus tricyclic antidepressants for the treatment of depression, anxiety and distressing symptoms of cancerCankurtaran, E. S. / Soygur, A. H. / Ozalp, E. / Turhan, L. et al. | 2006
- S325
-
P.2.c.024 Is mirtazapine in combination with perospirone efficacious in drug resistant depression? - Via 5-HT1A receptor activationMorita, M. / Nakayama, K. / Nakajyo, R. / Kusaka, A. / Kodaka, H. / Miyata, H. et al. | 2006
- S327
-
P.2.c.027 Suicidal behaviour and psychopharmaco-therapy in urgent psychiatry outpatients departmentPregelj, P. et al. | 2006
- S328
-
P.2.c.029 Early sustained improvement with escitalopram leads to high response ratesBurke, W. J. / Korotzer, A. / Saikali, K. et al. | 2006
- S329
-
P.2.c.031 Venlafaxine/mirtazapine-combination in treatment-resistant major depressionUllrich, H. / Pach, J. L. / Kudling, R. / Klieser, E. et al. | 2006
- S330
-
P.2.c.033 Clinical effectiveness of lamotrigine in recurrent major depressive disorder, resistant to other therapiesFricchione Parise, V. et al. | 2006
- S331
-
P.2.c.035 Research update from the latest STARD findingsTrivedi, M. H. / Fava, M. / Nierenberg, A. A. / Warden, D. / Wisniewski, S. R. / Rush, A. J. et al. | 2006
- S332
-
P.2.c.037 Depression:characteristics of patients who receive adequate, inadequate, or no treatment at allZivanovic, O. et al. | 2006
- S333
-
P.2.d.002 Wf-516, a novel antidepressant with dual serotonergic activity: II. Pharmacological profiles ex vivo and in vivo to monoamine transporters in comparison with standard antidepressantMaeda, J. / Morio, Y. / Katayama, J. / Horie, S. / Inaba, K. / Nishiyama, A. / Eguchi, J. / Saito, K. et al. | 2006
- S334
-
P.2.d.004 Evaluation of antidepressant activities of rose oil and geranium oil in the forced swim test in mouseKhalaj, L. / Farzin, D. et al. | 2006
- S336
-
P.2.d.007 Proteomic analysis of hippocampus and frontal cortex in a rat model of depression with gene-environment interaction and antidepressant treatmentCarboni, L. / Piubelli, C. / Vighini, M. / El Khoury, A. / Gruber, S. / Anderssen, W. / Mathe, A. A. / Aitchison, K. J. / Mallei, A. / Giambelli, R. et al. | 2006
- S337
-
P.2.d.009 Agomelatine, a novel pharmacological approach to treating depressionHamon, M. / Millan, M. J. et al. | 2006
- S338
-
P.2.d.011 Effects of the novel antidepressant agomelatine (S 20098) and fluoxetine in chronically stressed tree shrews, an animal model of depressionFuchs, E. / Schmelting, B. / Mocaer, E. et al. | 2006
- S339
-
P.2.d.013 TC-2216: anti-depressant effects through selective modulation of neuronal nicotinic receptorsLippiello, P. M. / Bencherif, M. / Gatto, G. J. / Jordan, K. G. / Traina, V. M. et al. | 2006
- S340
-
P.2.d.015 Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the ratKuteeva, E. / Wardi, T. / Hokfelt, T. / Ogren, S. O. et al. | 2006
- S342
-
P.2.d.018 Antidepressant-like effects of gabapentin and GABA-lactam analogues in the forced swimming test and in the tail suspension testMantovani, M. / Kaster, M. P. / Feuerstein, T. J. / Rodrigues, A. L. et al. | 2006
- S343
-
P.2.d.020 Antidepressant-like effect of guanosine in the forced swimming test and in the tail suspension testKaster, M. P. / Bonetti, K. M. / Santos, A. R. / Rodrigues, A. L. et al. | 2006
- S344
-
P.2.d.022 The modified Tail Suspension Test (mTST): a new paradigm to categorize antidepressants. Effects of classical and atypical opiatesBerrocoso, E. / Gibert-Rahola, J. / De Benito, M. D. / Mico, J. A. et al. | 2006
- S345
-
P.2.d.024 5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats: clinical implicationsSukoff Rizzo, S. J. / Schechter, L. E. / Rosenzweig-Lipson, S. et al. | 2006
- S346
-
P.2.e.001 Bipolar diathesis of unipolar treatment resistant depressionBahk, W. M. / Woo, Y. S. / Chae, J. H. / Jun, T. Y. / Kim, K. S. / Kim, W. et al. | 2006
- S348
-
P.2.e.005 Elevated urine Adam12 protein levels in lithium-treated bipolar patientsBersudsky, Y. / Nadri, C. / Belmaker, R. H. / Agam, G. et al. | 2006
- S349
-
P.2.e.007 Dopamine function in bipolar depressed patientsMonreal Ortiz, J. A. / Duval, F. / Mokrani, M. C. / Pinault, G. / Fattah, S. / Chokmani, N. / He, J. / Champeval, C. / Macher, J. P. et al. | 2006
- S350
-
P.2.e.009 Body weight changes in patients with acute mania treated with combination of mood stabilizer and atypical antipsychotic or typical antipsychoticKang, M. H. / Jeon, J. S. / Kim, C. E. / Lee, J. S. / Bae, J. N. et al. | 2006
- S351
-
P.2.e.011 Aggressive behaviour during acute mania: a cross-sectional study with 173 different manic patientsMosquera, F. / Barbeito, S. / Garcia del Moral, E. / Alvarez de Eulate, S. / Lopez, P. / Casado, M. / Gonzalez-Pinto, A. et al. | 2006
- S352
-
P.2.e.013 Symptoms of bipolarity in patients with eating disordersRybakowski, F. / Kaminska, K. et al. | 2006
- S353
-
P.2.e.015 The efficacy and tolerability of quetiapine monotherapy in acute maniaYoon, B. / Bahk, W. M. / Lee, J. / Won, S. / Lee, S. / Min, K. / Jon, D. / Chung, S. et al. | 2006
- S354
-
P.2.e.017 Safety, tolerability and ef .cacy of rapidly-initiated quetiapine in acutely ill patients with bipolar I disorderCobo, I. / Hernandez, J. / Vazquez-Gutierrez, F. / Galan, J. L. / Tafalla, M. et al. | 2006
- S355
-
P.2.e.019 Specificity of effect of quetiapine for depressive symptoms in bipolar disorderHirschfeld, R. M. / Calabrese, J. R. et al. | 2006
- S356
-
P.2.f.001 Cognitive functions and neurological soft signs among patients with bipolar disorder, trait or state marker?Rabie, M. / Sadek, A. / Soliman, A. / Ramy, H. et al. | 2006
- S357
-
P.2.g.001 Diagnostic stability in major depressive disorder as according to DSM-IVBahk, W. M. / Woo, Y. S. / Chae, J. H. / Jun, T. Y. / Kim, K. S. et al. | 2006
- S359
-
P.2.g.004 Severity of depression during the first year of vagus nerve stimulation in the group of non-respondersFrick, C. / Hosten, S. / Brodesser, D. / Kosel, M. / Axmacher, N. / Kuehn, K. U. / Brannan, S. / Maier, W. / Schlaepfer, T. E. et al. | 2006
- S360
-
P.2.g.006 Disparity in the rate of depression and use of antidepressants in the USA by ethnicity/race: 1992-2003Sclar, D. A. / Skaer, T. L. / Robison, L. M. et al. | 2006
- S361
-
P.2.g.008 Serum zinc level as potential marker in recurrent depressive disorderSiwek, M. / Dudek, D. / Datka, W. / Zieba, A. / Pilc, A. / Nowak, G. et al. | 2006
- S363
-
P.2.h.002 Plasma levels of nitric oxide metabolites in patients with postpartum depressionLee, B. H. / Shin, Y. C. / Kim, Y. K. / Kim, K. H. et al. | 2006
- S364
-
P.3.a.002 Elevated plasma copper/zinc ratios in patients with schizophreniaFarzin, D. / Mansouri, N. / Yazdani, T. et al. | 2006
- S365
-
P.3.a.004 Long acting risperidone in treatment of non-compliant bipolar patientsCetin, M. / Basoglu, C. / Ebrinc, S. U. / Semiz, B. / Algul, A. / Oguz, M. et al. | 2006
- S366
-
P.3.a.005 Exploring the socio-cultural components of prescription patterns in schizophrenia: a comparative studyXiang, Y. T. / Weng, Y. Z. / Ungvari, G. S. / Leung, C. M. / Tang, W. K. et al. | 2006
- S367
-
P.3.a.007 Measuring catatonia:application of an item response theory modelUngvari, G. S. / Wong, E. / Leung, S. K. / Tan, W. K. et al. | 2006
- S368
-
P.3.a.008 Schizophrenia with catatonic features: a factor analytic studyGoggins, W. / Ungvari, G. S. / Leung, S. K. / Ng, F. S. et al. | 2006
- S369
-
P.3.a.010 Risperidone long-acting injection: a one year observational study in a naturalistic settingPatel, M. X. / Young, C. / David, A. S. / Taylor, D. M. et al. | 2006
- S370
-
P.3.a.012 Low concentration of plasma nitric oxide metabolites in schizophrenic patientsLee, B. H. / Kim, Y. K. / Lee, K. M. et al. | 2006
- S372
-
P.3.a.016 Pharmacotherapy in schizophrenic patients and quality of life of their family membersTrajanovic, L. / Skakic, O. / Zikic, O. et al. | 2006
- S373
-
P.3.a.018 Vitamin D deficiency and impaired parathormone metabolism as a risk factor of low bone mineral density in patients with diagnosis of schizophrenia treated with second generation antipsychoticsWyszogrodzka-Kucharska, A. / Rabe-Jablonska, J. et al. | 2006
- S374
-
P.3.a.020 Subgroups within schizophrenia differentiated by clinical and neurocognitive parametersSzendi, I. / Cimmer, C. / Csifcsak, G. / Szekeres, G. / Kovacs, A. Z. / Galsi, G. / Racsmany, M. / Boda, K. / Janka, Z. et al. | 2006
- S375
-
P.3.a.021 Examination of specific genetic aspects of the dopaminergic neurotransmission and neuronal plasticity in neurocognitive subgrouping of schizophreniaSzendi, I. / Juhasz, A. / Szekeres, G. / Cimmer, C. / Csifcsak, G. / Kovacs, A. Z. / Rimanoczy, A. / Galsi, G. / Boda, K. / Janka, Z. et al. | 2006
- S376
-
P.3.a.023 Infiuence of glycine on cognitive functions in schizophreniaStrzelecki, D. / Rabe-Jablonska, J. et al. | 2006
- S377
-
P.3.a.025 Open-label randomized trial comparing the efficacy and tolerability of quetiapine and olanzapine in first episode psychosis in adolescentsParellada, M. J. / Moreno, D. / Ruiz-Sancho, A. / Medina, O. / Arango, C. et al. | 2006
- S378
-
P.3.a.027 In fluences of polymorphisms of beta adrenergic receptors in the psychopharmacological treatment of schizophreniaSpellmann, I. / Riedel, M. / Musil, R. L. / Douhet, A. / Dehning, S. / Zill, P. / Muller, N. / Moller, H. J. / Bondy, B. et al. | 2006
- S380
-
P.3.a.030 Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environmentWittchen, H. U. / Spauwen, J. / Krabbendam, L. / Lieb, R. / Van Os, J. et al. | 2006
- S381
-
P.3.a.032 Cognitive efficacy of quetiapine and olanzapine in early onset first episode psychosisRobles, O. / Zabala, A. / Parellada, M. J. / Ruiz, A. / Moreno, M. D. / Burdalo, M. T. / Arango, C. et al. | 2006
- S382
-
P.3.a.034 Negative symptoms of schizophrenia: analysis of a multinational, cross-sectional survey of physician perceptionsLecrubier, Y. / Perry, R. / Milligan, G. / Leeuwenkamp, O. et al. | 2006
- S384
-
P.3.a.037 Quality of life in bipolar type I disorder and schizophrenia in remission:clinical and neurocognitive correlatesBrissos, S. / Dias, V. V. / Carita, A. I. et al. | 2006
- S385
-
P.3.a.039 Onset of action of oral paliperidone extended-release tablets in patients with acute schizophrenia: pooled results from three 6-week controlled studiesKramer, M. / Nuamah, I. / Lim, P. / Eerdekens, M. et al. | 2006
- S387
-
P.3.a.042 Clinical course, social functioning, quality of life & medication tolerability in previously untreated patients with schizophrenia: 36-month results from the European schizophrenia outpatient health outcomes (SOHO) studyNovick, D. / Suarez, D. / Brown, J. / Gasquet, I. / Haro, J. M. et al. | 2006
- S388
-
P.3.a.044 Tobacco, alcohol and cannabis use in Tunisian patients with schizophreniaLaqueille, X. / Ghodhbane, S. / Nacef, F. / Choubani, Z. / Nehdi, M. / Douki, S. / Dervaux, A. et al. | 2006
- S389
-
P.3.a.046 Pseudophaeochromocytoma syndrome caused by clozapine therapy - a case reportSobanski, T. / Wagner, G. / Schubert, S. / Dafov, I. et al. | 2006
- S390
-
P.3.a.048 Insight in schizophrenia: clinical correlates and relationship to functioningGharabawi, G. M. / Bossie, C. A. / Bouhours, P. / Turkoz, I. / Kujawa, M. et al. | 2006
- S391
-
P.3.b.001 Polymorphisms of dysbindin gene (DTNBP1) and schizophrenia in the Korean populationJun, T. Y. / Bahk, W. M. / Chae, J. H. / Pae, C. U. / Jung, Y. E. / Lee, B. W. / Bang, S. K. / Woo, Y. S. et al. | 2006
- S392
-
P.3.b.002 Stereotypy in schizophrenic patients on atypical antipsychotics versus conventional neurolepticsMorrens, M. / Hulstijn, W. / Sabbe, B. G. et al. | 2006
- S393
-
P.3.b.004 Evidence of a cortical disinhibition in schizophrenia: a transcranial magnetic stimulation studyBen Amor, C. / Galinowski, A. / Gueguen, B. / Bourdel, M. C. / Olie, J. P. / Douki, S. / Krebs, M. O. et al. | 2006
- S394
-
P.3.b.006 Relationship between glutathione peroxidase activity, glutathione and selenium levels in schizophrenic patientsMechri, A. / Mekhinini, A. / Ben Othman, L. / Fendri, C. / Gaha, L. / Kerkeni, A. et al. | 2006
- S395
-
P.3.b.008 Oxidative stress and neurodevelopmental abnormalities in schizophreniaMechri, A. / Fendri, C. / Slama, H. / Ben Othman, L. / Kerkeni, A. / Gaha, L. et al. | 2006
- S396
-
P.3.c.001 A randomized double blind clinical trial in famotidine adjuvant therapy in schizophreniaFarzin, D. / Hosseini, S. H. / Shafaat, A. et al. | 2006
- S397
-
P.3.c.003 Olanzapine versus ziprasidone in parenteral administration in psychotic relapse of schizophreniaTudor, C. / Ungureanu, D. / Gheorghe, M. D. et al. | 2006
- S399
-
P.3.c.006 A pilot crossover study on QTc interval associated with olanzapine and risperidoneSu, K. P. / Huang, C. L. / Hsu, H. B. / Pariante, C. M. et al. | 2006
- S400
-
P.3.c.008 Weight change after switching from olanzapine tablets to olanzapine orally disintegrated tablets in obese patients with schizophreniaChawla, B. / Luxton-Andrew, H. et al. | 2006
- S401
-
P.3.c.010 Asenapine safety and tolerability in acute schizophrenia: a placebo-and risperidone-controlled trialPotkin, S. G. / Cohen, M. / Panagides, J. / Jina, A. et al. | 2006
- S402
-
P.3.c.012 Discontinuation rate of antipsychotic drugs in the treatment of first treated schizophreniaShim, J. C. / Choe, B. M. / Jae, Y. M. / Kim, J. G. / Kim, H. C. / Kim, S. G. et al. | 2006
- S404
-
P.3.c.015 Pre-attentive processes and attention: effect of risperidone for 6 weeks in untreated patients with schizophrenia and correlation with disorganizationAmado, I. / Daban, C. / Poirier, M. F. / Bourdel, M. C. / Willard, D. / Bouhours, P. / Loo, H. / Krebs, M. O. et al. | 2006
- S405
-
P.3.c.017 Adjunctive treatment with a dopamine partial agonist, aripiprazole for antipsychotic induced hyperprolactinemiaShim, J. C. / Kelly, D. L. / Jung, D. U. / Seo, Y. S. / Kim, Y. H. / Conley, R. R. et al. | 2006
- S406
-
P.3.c.019 Patient compliance and efficacy of quetiapine treatment in schizophrenia: results of six-month follow-up studyAlptekin, K. et al. | 2006
- S407
-
P.3.c.021 Patterns of antipsychotic-induced weight change: 3-year results from the intercontinental schizophrenia outpatient-health outcomes (IC-SOHO) studyDossenbach, M. / Pachecho, Z. / Toledo, D. / Cornejo, R. / West, T. / Lowry, A. et al. | 2006
- S408
-
P.3.c.022 Amelioration of symptomatology, Parkinsonism and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in schizophreniaStrous, R. D. / Stryjer, R. / Maayan, R. / Gal, G. / Eisner, D. / Weizman, A. et al. | 2006
- S409
-
P.3.c.024 Negative and cognitive symptomatology improvement during aripiprazole treatment in chronic schizophreniaGheorghe, M. D. / Voicu, V. A. / Vasile, D. / Vasiliu, O. / Grigorescu, G. et al. | 2006
- S410
-
P.3.c.026 Remission of tardive dyskinesia following the switch from clozapine to zotepine: 2-year follow-upLin, C. C. / Chen, J. Y. / Bai, Y. M. / Chen, T. T. / Wang, Y. C. / Liou, Y. J. / Lin, W. K. et al. | 2006
- S411
-
P.3.c.028 Effectiveness of aripiprazole versus standard of care treatment in patients with schizophrenia: the Schizophrenia Trial of Aripiprazole (STAR) studyKerwin, R. / LItalien, G. / Hanssens, L. / Marcus, R. N. / McQuade, R. / Carson, W. H. / Beuzen, J. N. et al. | 2006
- S412
-
P.3.c.030 Serotonin 2c receptor gene polymorphisms in association with extrapyramidal side-effects in schizophrenic patientsGunes, A. / Dahl, M. L. / Spina, E. / Scordo, M. G. et al. | 2006
- S413
-
P.3.c.032 Risperidone long acting im formulation in high risk of noncompliance bipolar patientsVasile, D. / Vasiliu, O. / Ojog, D. / Gheorghe, M. D. et al. | 2006
- S414
-
P.3.c.034 Comparing the use and outcomes of antipsychotics in the real worldTaylor, A. M. / Shajahan, P. / Carleton, R. et al. | 2006
- S415
-
P.3.c.036 Clinical efficacy, body weight change and cardiac safety of zotepine in schizophrenic patientsLin, W. W. / Chen, H. K. et al. | 2006
- S416
-
P.3.c.038 Switching from other second generation antipsychotics to zotepine in schizophrenic patients: an 12-week open-label studyChen, J. Y. / Chen, T. T. / Lin, C. C. / Bai, Y. M. / Wu, B. J. / Hung, C. H. et al. | 2006
- S417
-
P.3.c.040 The comparison of efficacy between aripiprazole and haloperidol in treatment of chronic schizophrenia and schizoaffective disorder: results for 16-week clinical studyKim, J. G. / Cho, D. H. / Lee, S. J. / Lee, J. K. / Wang, K. S. / Seo, Y. I. / Choi, S. J. / Joo, M. J. / Kim, H. D. / Lee, K. H. et al. | 2006
- S418
-
P.3.c.041 -759 C/T polymorphism of the 5-HT2C receptor gene and antipsychotic drug-induced weight gainRyu, S. H. / Jang, W. S. / Cho, E. Y. / Kim, S. K. / Lee, D. S. / Park, T. S. / Oh, S. H. / Hong, K. S. et al. | 2006
- S419
-
P.3.c.043 Association of leptin gene polymorphism with antipsychotic drug-induced weight gainRyu, S. H. / Jang, W. S. / Cho, E. Y. / Kim, S. K. / Lee, D. S. / Hong, K. S. et al. | 2006
- S420
-
P.3.c.045 Treatment of agitation caused by severe mental illness: data from the South London and Maudsley intensive care units trial evaluation (SLAMICUTE) studyMantua, V. / Travis, M. J. / Atakan, Z. / Isaac, M. B. / Isaac, M. T. / Smith, S. / Gilbert, D. / Komeh, J. / Shaw, A. / Sweeney, C. et al. | 2006
- S422
-
P.3.c.048 Antipsychotic safety: should we believe in guinea-pigsBarrocas, D. / Abreu, M. / Figueira, L. et al. | 2006
- S423
-
P.3.c.050 Psychopathology and metabolic syndrome (MS) in psychotic patients: the CLAMORS studyArango, C. / Bobes, J. / Aranda, P. / Carmena, R. / Garcia-Garcia, M. / Rejas, J. et al. | 2006
- S424
-
P.3.c.052 Quetiapine monotherapy is efficacious for depressive episodes of bipolar I and II disorder: a confirmatory double-blind study (BOLDER II)Thase, M. E. / Macfadden, W. / McCoy, R. / Chang, W. / Calabrese, J. R. et al. | 2006
- S425
-
P.3.c.054 Olanzapine, quetiapine, and risperidone in the treatment of first-episode psychosis: effectiveness and factors influencing adherence to treatmentMcEvoy, J. P. / Perkins, D. O. / Gu, H. / Hamer, R. M. / Lieberman, J. A. et al. | 2006
- S427
-
P.3.c.058 Emotion recognition deficit in first-episode schizophrenic patients and atypical antipsychoticsAmminger, G. P. / Werneck-Rohrer, S. W. / Aschauer, H. N. / Edwards, J. E. / Schloegelhofer, M. S. et al. | 2006
- S428
-
P.3.c.059 Clozapine and amisulpride in a treatment resistant schizophrenic patient with alcohol dependence and diabetes comorbidityDervaux, A. / Cazali, J. et al. | 2006
- S429
-
P.3.d.001 Effects of bifeprunox on the rat ventral tegmental area dopamine and dorsal raphe serotonin neuronal activityDahan, L. / Mnie-Filali, O. / Arnt, J. / Hertel, P. / Haddjeri, N. et al. | 2006
- S430
-
P.3.d.003 A cross-sectional study of adiponectin in patients with schizophreniaHanssens, L. / DeHert, M. / Van Eyck, D. / Wampers, M. / Scheen, A. / Peuskens, J. et al. | 2006
- S431
-
P.3.d.005 Effects of novel antipsychotics with preferential activity at D2-like and 5-HT1A receptors, in comparison with typical and atypical reference antipsychotics, in rodent models of cognition and memory deficitBardin, L. / Newman-Tancredi, A. / Depoortere, R. et al. | 2006
- S432
-
P.3.d.007 F15063, a novel antipsychotic with dopamine D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: III. Duration of brain D2-like receptor occupancy, antipsychotic-like activity and plasma concentration in rodentsAssie, M. B. / Bardin, L. / Auclair, A. L. / Consul-Denjean, N. / Sautel, F. / Kleven, M. S. / Depoortere, R. / Newman-Tancredi, A. et al. | 2006
- S434
-
P.3.d.010 Neonatal endotoxin administration induces behavioural changes in young adult rat males: implications for the etiopathogenesis of schizophreniaTejkalova, H. / Klaschka, J. / Stastny, F. et al. | 2006
- S435
-
P.3.d.012 The response of clozapine on midbrain dopamine neurons depends on endogenous concentration of kynurenic acidSchwieler, L. / Linderholm, K. R. / Nilsson, L. K. / Engberg, G. / Erhardt, S. et al. | 2006
- S436
-
P.3.d.014 Anti-S100 antibodies ameliorate haloperidol-induced catalepsy and do not change the activity of haloperidol in apomorphine-induced stereotypyDugina, J. L. / Kheifez, I. A. / Martyushev-Poklad, A. V. / Voronina, T. A. / Molodavkin, G. M. / Epstein, O. I. / Sergeva, S. A. et al. | 2006
- S439
-
P.3.d.019 Chronic olanzapine treatment affects intracellular signalling in selected subcellular compartments of rat prefrontal cortexFumagalli, F. / Frasca, A. / Sparta, M. / Drago, F. / Racagni, G. / Riva, M. A. et al. | 2006
- S440
-
P.3.d.021 Physostigmine reverses MK-801-induced but not amphetamine-induced effects on latent inhibition: focus on cholinergic treatments in schizophreniaBarak, S. / Weiner, I. et al. | 2006
- S441
-
P.3.d.023 Efficacy of a psychoeducational program for weight loss in patients who have experienced weight gain during treatment with olanzapineCastrogiovanni, S. / Simoncini, M. / Iovieno, N. / Cecconi, D. / Dell Agnello, G. / Donda, P. / Quadrigli, M. / Rossi, A. / Mauri, M. et al. | 2006
- S442
-
P.3.e.002 Clinical evaluation of levopromazine (methotrimeprazine) as add-on therapy in fibromyalgia managementMorillas-Arques, P. / Rodriguez-Lopez, C. M. / Vilchez, J. S. / Hidalgo, J. / Rico-Villademoros, F. / Calandre, E. P. et al. | 2006
- S443
-
P.3.e.003 Dissociation of working memory from decision-making in schizophreniaKweon, Y. S. / Lee, K. U. / Lee, S. J. / Kim, Y. T. / Kim, S. H. / Jeung, S. H. / Lee, H. K. / Lee, J. T. et al. | 2006
- S444
-
P.3.e.005 Influencing negative symptoms of schizophrenia with repetitive transcranial magnetic stimulation: a pilot studyPrikryl, R. / Ustohal, L. / Kasparek, T. / Kucerova, H. / Ceskova, E. / Skotakova, S. et al. | 2006
- S445
-
P.3.e.007 Risperidone oral solution, therapeutic possibility in treatment of acute and agitated psychotic patientsLasic, D. / Rubesa, G. / Dodig, G. / Katavic, Z. / Glavina, T. / Zuljan-Cvitanovic, M. et al. | 2006
- S446
-
P.3.e.009 Cognitive enhancement in schizophrenia: the role of dopamine and noradrenaline in the prefrontal cortexLopez-Garcia, P. / Snitz, B. / Smedley, K. / Carter, C. S. et al. | 2006
- S447
-
P.3.f.002 The 5-HT6 receptor antagonists, SB271,046 and SB258,585, enhance social memory and cholinergic transmission in rats: a comparison with 5-HT1A receptor partial agonistsLoiseau, F. / Millan, M. J. / Rivet, J. M. / Gobert, A. / De Groote, L. / Sicard, D. / Di Cara, B. / Cistarelli, L. / Billiras, R. / Dekeyne, A. et al. | 2006
- S448
-
P.4.a.001 A study of venlafaxine plus long-acting form of risperidone in patients with treatment-resistant obsessive compulsive disorder: preliminary resultsOzdemir, S. / Kocabasoglu, N. et al. | 2006
- S451
-
P.4.a.007 Natural course of obsessive compulsive disorder (OCD) over four years: findings from a prospective community study of adolescents and young adultsLieb, R. / Schwender, L. / Nocon, A. / Pfister, H. / Wittchen, H. U. et al. | 2006
- S452
-
P.4.a.009 Developmental trajectories of anxiety disorders in offspring at high risk for panic disorderBiederman, J. / Petty, C. / Hirshfeld-Becker, D. / Henin, A. / Henry, B. / Faraone, S. V. / Rosenbaum, J. F. et al. | 2006
- S453
-
P.4.a.011 Longitudinal course of posttraumatic stress disorder and posttraumatic stress disorder symptoms in a community sample of adolescents and young adultsPerkonigg, A. / Pfister, H. / Stein, M. B. / Hoefler, M. / Lieb, R. / Maercker, A. / Wittchen, H. U. et al. | 2006
- S455
-
P.4.a.014 Association and temporal relation of generalized anxiety and pain in the first three decades of life: a 10-year follow-up study among adolescents and young adultBeesdo, K. / Wittchen, H. U. / Guenther, A. / Lieb, R. et al. | 2006
- S456
-
P.4.a.016 Alcohol consumption in first stages of panic disorder: relationships with symptoms and impairmentRodriguez-Cabo, B. / Herran, A. / Ramirez, M. L. / Carrera, M. / Ayestaran, A. / Sierra-Biddle, D. / Hoyuela, F. / Vazquez-Barquero, J. L. et al. | 2006
- S457
-
P.4.a.018 The effects of D-cycloserine on a cognitive function task under different states of anxiety in healthy volunteersBailey, J. E. / Papadopoulos, A. / Nutt, D. J. et al. | 2006
- S458
-
P.4.a.020 Efficacy and safety of pregabalin for the treatment of generalized anxiety disorder in elderly patientsMontgomery, S. A. / Chatamra, K. / Baldinetti, F. / Whalen, E. et al. | 2006
- S459
-
P.4.a.022 Association study of limbic system-associated membrane protein gene polymorphisms in panic disorderMaron, E. / Koido, K. / Must, A. / Reimets, A. / Koks, S. / Vasar, E. / Vasar, V. / Shlik, J. et al. | 2006
- S460
-
P.4.b.002 The central neuropeptide S system: expression, pharmacology and behavioural significance of neuropeptide S receptorsLeonard, S. K. / Kouranova, E. / Bender, C. / Malberg, J. E. / Schechter, L. E. / Luo, B. / Platt, B. / Potestio, L. / Beyer, C. E. / Rosenzweig-Lipson, S. et al. | 2006
- S461
-
P.4.b.004 Stimulation of the lateral habenula inhibits a panic-like behaviour by activation of serotonin-1A receptors in the rat dorsal periaqueductal grayPobbe, R. L. / Bertoglio, L. J. / Zangrossi, H. et al. | 2006
- S462
-
P.4.b.006 Inhibition of nitric oxide synthase in the dorsolateral periaqueductal grey decreases behavioural consequences of predator exposure in ratsAguiar, D. C. / Guimaraes, F. S. et al. | 2006
- S464
-
P.4.c.001 Adjunctive quetiapine for SRI-resistant obsessive compulsive disorder: a meta-analysis of three randomised controlled treatment trialsFineberg, N. A. / Stein, D. J. / Carey, P. / Vythilingum, B. / Sivakumaran, T. / Seedat, S. / Westenberg, H. / Denys, D. / Premkumar, P. et al. | 2006
- S465
-
P.4.c.003 Predictors of clinical outcome in panic disorder: a pooled analysis of venlafaxine extended release short-term treatment studiesPollack, M. / Stein, D. J. / Mangano, R. / Entsuah, R. / Simon, N. et al. | 2006
- S466
-
P.4.c.005 Pregabalins efficacy in achieving remission in outpatients with generalized anxiety disorderWittchen, H. U. / Baldinetti, F. et al. | 2006
- S467
-
P.4.d.001 Effect of ELB139, a subtype selectivie benzodiazepine agonist, on EEG in ratsLangen, B. / Unverferth, K. / Rundfeldt, C. et al. | 2006
- S468
-
P.4.d.003 Brief exposure of mice to a predator induces memory impairment in the object recognition task-effects of acute and chronic treatment by diazepam and imipramineBertaina-Anglade, V. / Enjuanes, E. / Drieu la Rochelle, C. et al. | 2006
- S469
-
P.4.d.005 Pregabalin acts at calcium channel alpha2-delta type 1 proteins to prevent acute stress-induced increases in cerebellar cGMPCampbell, B. M. / Morrison, J. L. / Taylor, C. et al. | 2006
- S470
-
P.4.e.001 Low frequency repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled studySong, J. M. / Pae, C. U. / Lee, Y. J. / Bahk, W. M. / Jun, T. Y. / Hahm, W. / Chae, J. H. et al. | 2006
- S471
-
P.4.e.002 Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depressionAouizerate, B. / Martin-Guehl, C. / Cuny, E. / Guehl, D. / Amieva, H. / Benazzouz, A. / Fabrigoule, C. / Allard, M. / Rougier, A. / Bioulac, B. et al. | 2006
- S472
-
P.4.e.004 Trait stability and agoraphobia in a one year follow up panic disorder sampleHoyuela, F. / Carrera, M. / Ramirez, M. M. / Rodriguez-Cabo, B. / Ayestaran, A. / Sierra-Biddle, D. / Herran, A. / Vazquez-Barquero, J. L. et al. | 2006
- S473
-
P.4.e.005 The effect of acute tryptophan depletion on challenge induced anxiety in anxiety disorder patients is independent of a history of depressionHood, S. D. / Argyropoulos, S. V. / Davies, S. J. / Hince, D. A. / Bell, C. J. / Nutt, D. J. / Potokar, J. et al. | 2006
- S474
-
P.4.f.001 Differential behaviour in the marble-burying test does not predict behavioural differences in generalized anxiety disorder modelsCosta, M. / Costa, C. R. / Gargano, A. C. / Ledvinka-Filho, E. et al. | 2006
- S475
-
P.4.f.003 EPIA -anxiety as a trait in SlovakiaHeretik, A. / Novotny, V. / Pecenak, J. / Ritomsky, A. et al. | 2006
- S476
-
P.5.a.002 Relationships between writing errors and cognitive impairment in elderly psychiatric patientsTamasan, S. C. / Reisz, D. et al. | 2006
- S477
-
P.5.a.004 Validity of the Korean version of the Mini-CogChoi, Y. M. / Lee, D. W. / Lee, J. Y. et al. | 2006
- S478
-
P.5.a.006 Impact of Apo-E genotype on the response to donepezil therapy in patients with Alzheimers diseaseScordo, M. G. / Varsaldi, F. / Arena, M. G. / Villa, M. L. / Lombardi, G. / Cordici, F. / Dahl, M. L. et al. | 2006
- S480
-
P.5.a.009 Effects of long term treatment with cholinesterase inhibitors on sleep EEG in patients with dementia of Alzheimer and frontotemporal typeHemmeter, U. M. / Rocamora, R. / Thum, A. / Giesler, M. / Haag, A. / Becker, A. / Krieg, J. C. et al. | 2006
- S481
-
P.5.a.011 Efficacy and safety of donepezil in vascular dementia:results from the largest double-blind trial in vascular dementia patientsRoman, G. / Black, S. / Royall, D. R. / Surick, I. / Kumar, D. / Schindler, R. / Posner, H. et al. | 2006
- S482
-
P.5.b.002 Magnetic resonance spectroscopy in patients with alcoholic dementiaGo, H. J. / Cheon, Y. H. / Ahn, K. / Kim, Y. D. / Kim, D. et al. | 2006
- S483
-
P.5.b.004 Effects of memantine on the activity of secretase enzymes in the human neuroblastoma cellsLahiri, D. K. / Chen, D. / Alley, G. M. / Banerjee, P. K. et al. | 2006
- S484
-
P.5.b.006 Age-dependent changes in hippocampal glutamate levels parallel learning impairment in APP/PS1 transgenic miceMinkeviciene, R. / Ihalainen, J. / Malm, T. / Keksa-Goldsteine, V. / Leguit, N. / Glennon, J. / Banerjee, P. K. / Tanila, H. et al. | 2006
- S486
-
P.5.d.002 Phospholipase D activation as a possible apoptotic signal in ischemic astrocytesKrzystanek, M. / Krupka-Matuszczyk, I. / Trzeciak, H. I. / Krzystanek, E. et al. | 2006
- S487
-
P.5.e.002 An open-label study of quetiapine for deliriumManeeton, N. / Maneeton, B. / Srisurapanont, M. et al. | 2006
- S488
-
P.5.e.004 A comparative study of haloperidol and quetiapine in the treatment of delirium: a preliminary randomized open label, flexible dose trialLee, Y. / Lee, J. / Rim, H. D. / Kim, S. H. / Chung, U. S. / Cho, G. A. / Won, S. H. et al. | 2006
- S489
-
P.6.a.001 Efficacy and safety of aripiprazole for the treatment of craving and relapse prevention in dually diagnosed alcohol dependent subjects: a pilot studyMartinotti, G. / Di Nicola, M. / Andreoli, S. / Di Maria, G. / Reina, D. / Janiri, L. et al. | 2006
- S492
-
P.6.a.007 Risks and pattern of alcohol withdrawal deliriumManeeton, B. / Burapakajornpong, N. / Srisurapanont, M. et al. | 2006
- S494
-
P.6.a.011 Childhood adversity associated with reduced central dopamine sensitivity later in life, a pre-morbid vulnerability to develop alcohol dependence?Schellekens, A. F. / Ellenbroek, A. / De Jong, C. A. / Buitelaar, J. K. / Verkes, R. J. et al. | 2006
- S495
-
P.6.a.013 Sleep problems in alcohol dependencePaparrigopoulos, T. J. / Tzavellas, E. O. / Liappas, J. A. / Soldatos, C. R. et al. | 2006
- S496
-
P.6.b.001 The endocannabinoid system in the effects of alcohol on limbic neurons:an in vivo electrophysiological studyPistis, M. / Perra, S. / Pillolla, G. / Muntoni, A. L. / Melis, M. et al. | 2006
- S498
-
P.6.b.004 Effect of amino acid derivatives and lipoic acid on lipid peroxidation and antioxidant systems indices in the rat brain during alcohol withdrawalPronko, P. S. / Khomich, T. I. / Bardina, L. R. / Satanovskaya, V. I. / Borodich, O. A. et al. | 2006
- S499
-
P.6.b.006 The role of epigenetic HERP dysregulation in patients with alcohol dependenceBleich, S. / Lenz, B. / Bonsch, D. / Frieling, H. et al. | 2006
- S500
-
P.6.c.001 Benzodiazepines misuse in outpatients treated by internistsSrisurapanont, M. / Suttajit, S. / Lerttrakarnnon, P. et al. | 2006
- S502
-
P.6.c.004 Are benzodiazepine expenses judiciously invested?Irurita, J. / Irurita, M. / Deniz, C. / Martinez Saavedra, M. T. / Culebras, C. / Rodriguez, M. S. / Ania, B. / Saavedra, J. M. / Chirino, R. / Sanchez, F. et al. | 2006
- S503
-
P.6.c.006 The treatment of heroin withdrawal with dextromethorphan in Han Chinese: a randomized double-blind placebo-controlled trialLin, W. W. / Tao, P. L. / Lee, J. F. / Lu, R. B. / Ko, H. C. et al. | 2006
- S504
-
P.6.c.008 One year retention rates and outcomes methadone and buprenorphine maintenance treatments: a nationwide prospective-longitudinal study of 2694 patientsWittchen, H. U. / Apelt, S. M. / Soyka, M. / Gastpar, M. / Backmund, M. / Goelz, J. / Kraus, M. / Tretter, F. / Schaefer, M. / Siegert, J. et al. | 2006
- S505
-
P.6.c.010 The effects of cannabinoids in man: a systematic review of neuroimaging studiesFagundo, A. B. / Martin-Santos, R. / Crippa, J. A. / Seal, M. / Atakan, Z. / McGuire, P. et al. | 2006
- S507
-
P.6.d.001 Ascorbic acid attenuates naloxone-induced withdrawal signs in morphine-dependent guinea-pigsFarzin, D. et al. | 2006
- S508
-
P.6.d.003 A morphometric evaluation of rat foetal cerebrum after maternal administration of morphine sulfateSadraie, S. H. / Kaka, G. et al. | 2006
- S509
-
P.6.d.005 mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behaviour in ratsDravolina, O. / Zakharova, E. S. / Shekunova, E. V. / Zvartau, E. E. / Danysz, W. / Bespalov, A. Y. et al. | 2006
- S510
-
P.6.d.007 Evaluation of the role of 5-HT1A receptors in dorsal and median raphe nuclei on the morphine withdrawal syndrome in ratCharkhpour, M. / Nayebi, A. M. et al. | 2006
- S512
-
P.6.d.011 Gender differences in effects of MDMA, cannabinoid agonist and their combinations in miceKucerova, J. / Landa, L. / Slais, K. / Sulcova, A. E. et al. | 2006
- S513
-
P.6.d.013 GABA(B) receptor agonists and a positive modulator reduce the "depressive-like" behaviours in rats during cocaine abstinenceFilip, M. / Frankowska, M. / Golda, A. / Zaniewska, M. / Przegalinski, E. et al. | 2006
- S514
-
P.6.d.015 MDMA self-administration is abolished in serotonin transporter knockout miceTrigo Diaz, J. M. / Renoir, T. / Lanfumey, L. / Hamon, M. / Robledo, P. / Maldonado, R. et al. | 2006
- S516
-
P.6.d.018 New group of positive modulators of AMPA-receptors with cognition enhancing propertiesGrigoriev, V. V. / Lavrov, M. / Palyulin, V. A. / Zefirov, N. S. / Besnosko, B. K. / Bachurin, S. O. et al. | 2006
- S517
-
P.6.d.020 CB1 cannabinoid and m opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212 -2Fattore, L. / Vigano, D. / Fadda, P. / Rubino, T. / Parolaro, D. / Fratta, W. et al. | 2006
- S518
-
P.6.d.022 Behavioural responses induced by nicotine in delta-opioid receptor knockout miceBerrendero, F. / Galeote, L. / Bura, A. / Kieffer, B. L. / Maldonado, R. et al. | 2006
- S519
-
P.6.d.024 C385A FAAH SNP is related to substance use disorder but not to schizophrenia in a Spanish sampleMartinez-Gras, I. / Ponce, G. / Rodriguez-Jimenez, R. / Rubio, G. et al. | 2006
- S520
-
P.6.e.002 Efficacy of sertraline in the treatment of alcohol dependenceLazarova, V. L. / Jakovcevska Kujundziska, M. J. / Filovska, V. F. / Krstevska, R. K. et al. | 2006
- S521
-
P.6.f.001 Is drive satisfaction mechanism ("antidrive") involved in substance addiction?Kostowski, W. / Beck, J. et al. | 2006
- S522
-
P.6.f.003 Effects of neonatal serotonin depletion on reinforcing and rewarding properties of cocaine in ratsStefanski, R. / Krzascik, P. / Kolomanska, P. / Rock, P. / Wyszogrodzka, E. / Kostowski, W. et al. | 2006
- S523
-
P.7.a.002 Use of levetiracetam in Aspergers Disorder patients: an open-label trialMech, A. W. et al. | 2006
- S524
-
P.7.a.004 The difference of IQ and behavioural problems among ADHD children showing modality-specific attention problemSon, J. W. / Lee, S. I. / Kim, S. K. / Shin, C. J. et al. | 2006
- S525
-
P.7.b.001 Prefrontal N-acetyl-aspartate and cognition in adolescents with first-episode psychosisZabala, A. / Sanchez, J. / Robles, O. / Moreno, D. / Burdalo, M. T. / Parellada, M. J. / Laita, P. / Desco, M. / Arango, C. et al. | 2006
- S526
-
P.7.c.001 Akathisia as frequent side effect of anaesthesia with neuroleptics in patients with attention deficit/hyperactivity disorderKrause, J. / Krause, K. H. et al. | 2006
- S527
-
P.7.c.003 Atomoxetine in the treatment of psychostimulant-naive children and adolescents with ADHD: a 6-week, randomized, placebo-controlled trial in RussiaMartenyi, F. / Zavadenko, N. / Jarkova, N. et al. | 2006
- S529
-
P.7.c.006 Antipsychotic drugs in children and adolescents: QTc interval elongationLaita, P. / Franco, C. / Llorente, C. / Cifuentes, A. / Ulloa, A. / Fraguas, D. / Arango, C. et al. | 2006
- S530
-
P.7.c.008 The clinical characteristics of the adolescent attention deficit/hyperactivity disorder (ADHD) patients and treatment effects of an extended-release preparation of methylphenidate (more large sample size than previous study)Oh, E. Y. et al. | 2006
- S531
-
P.7.d.001 Functional MRI of response inhibition in autismAnagnostou, E. / Fan, J. / Hollander, E. et al. | 2006
- S533
-
P.7.d.004 A preliminary study for standardization of the PSQ-K (paediatric sleep questionnaire -Korean version) in Korean childrenKweon, Y. S. / Jeun, W. H. / Lee, J. H. / Lee, H. K. / Lee, K. U. / Lee, J. T. et al. | 2006
- S534
-
P.7.e.002 Concentrations and glycosylations profile of acute phase proteins in anorexia nervosaKomorowska-Pietrzykowska, R. / Rajewski, A. / Sobieska, M. / Wiktorowicz, K. et al. | 2006
- S535
-
P.8.a.002 Quality of life in vitiligo and chronic urticaria patientsSukan, M. / Maner, F. et al. | 2006
- S536
-
P.8.a.004 Nocturnal eating episodes after taking zolpidem: are they sleep problems or eating problems?Kim, J. M. / Kim, Y. C. / Shin, H. B. / Lim, W. J. / Yun, K. W. / Paik, K. W. et al. | 2006
- S537
-
P.8.a.006 Can treatment of depression in primary care be improved with group counselling and patient education?Hansson, M. / Bodlund, O. et al. | 2006
- S538
-
P.8.a.008 The utility of structural neuroimaging in the psychiatric inpatientsPerez, M. P. / Prado, Y. P. / Paramo, M. P. et al. | 2006
- S539
-
P.8.a.010 Effects of galantamine on serum vitamin B12 and folic acid levels in patients with chronic fatigue immune dysfunction syndromeAsdemir, A. / Ozsoy, S. / Izgi, H. B. / Kula, M. / Deveci, M. / Yildiz, B. / Turan, T. / Esel, E. / Basturk, M. / Kirnap, M. et al. | 2006
- S541
-
P.8.a.014 Long-term evolution follow-up of patients treated with electroconvulsive therapyTajes, M. T. / Martinez, S. M. / Paramo, M. P. et al. | 2006
- S542
-
P.8.a.016 Impact of cerebrovascular accident on medical service resource utilization in a regional hospitalSicras Mainar, A. / Navarro Artieda, R. / Blanca Tamayo, M. / Llopart Lopez, J. R. / Serrat Tarres, J. / Rejas Gutierrez, J. et al. | 2006
- S544
-
P.8.a.019 Seasonally of cortisol secretionMorera, A. L. / Abreu, P. / Henry, M. / Garcia-Hernandez, A. / Guillen-Pino, F. / Gracia, R. et al. | 2006
- S545
-
P.8.a.021 Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with ADHDBiederman, J. / Spencer, T. J. / Mick, E. et al. | 2006
- S546
-
P.8.a.023 Lifetime comorbidity in bipolar disorder: bipolar subtype and gender differencesGrabski, B. / Dudek, D. / Datka, W. / Maczka, G. / Zieba, A. et al. | 2006
- S547
-
P.8.a.025 Testosterone levels in young male patients with affective disorder and schizophreniaRajewska-Rager, A. / Rajewska, J. / Kaminska, K. / Rybakowski, J. et al. | 2006
- S548
-
P.8.a.028 The role of gender in mixed mania: testing different definitions for mixed manic statesAldama, A. / Mosquera, F. / Gonzalez, C. / Ron, S. / Pecina, J. R. / Aspiazu, S. / Gonzalez-Pinto, A. et al. | 2006
- S551
-
P.8.a.033 Case-report of right unilateral anterior capsulotomy for obsessive-compulsive disorderDegraeve, G. / Audenaert, K. / Van Den Abbeele, D. / Van Heeringen, C. / Caemaert, J. / Van Roost, D. et al. | 2006
- S552
-
P.8.a.035 Lorazepam-induced reduction in activity mirrors decrements in cognitive and psychomotor performanceDawson, J. / Boyle, J. / Stanley, N. / Johnsen, S. / Hindmarch, I. / Skene, D. J. et al. | 2006
- S553
-
P.8.a.037 The Verona brain imaging study in schizophrenia: an integrated project with epidemiology and social psychiatryDusi, N. / Tansella, M. / Versace, A. / Andreone, N. / Rambaldelli, G. / Perlini, C. / Barbui, C. / Nose, M. / Cristofalo, D. / Gasparini, A. et al. | 2006
- S554
-
P.8.a.039 Driving ability in adults with attention-deficit hyperactivity disorder significantly improves when treated with methylphenidateVerster, J. C. / Bekker, E. M. / De Roos, M. / Minova, A. / Eijken, E. J. / Kooij, U. S. / Buitelaar, J. K. / Kenemans, J. L. / Verbaten, M. N. / Olivier, B. et al. | 2006
- S555
-
P.8.a.041 The correlation of dream recall and clinical variables in narcolepticsLee, S. P. / Jeong, J. H. / Hong, S. H. / Han, J. H. et al. | 2006
- S556
-
P.8.a.042 Persistent executive deficit in euthymic bipolar outpatients: a 2-year follow-up studyMur, M. / Portella, M. J. / Martinez-Aran, A. / Pifarre, J. / Vieta, E. et al. | 2006
- S557
-
P.8.a.044 Neuropsychological functioning in stabilised patients after a first psychotic episodeJimenez, A. / Gonzalez Gomez, C. / Palomino, A. / Dominguez, M. G. / Vega, P. / Gonzalez Oliveros, R. / Gonzalez-Pinto, A. et al. | 2006
- S558
-
P.8.a.046 Are zolpidem-induced amnesia and somnambulism rare incidences?Chen, C. C. / Yang, P. / Chung, W. L. / Chour1, W. Y. et al. | 2006
- S559
-
P.8.a.048 Childhood physical and sexual abuse in 100 nonviolent suicide attempters in BudapestRihmer, A. / Rozsa, S. / Rihmer, Z. et al. | 2006
- S560
-
P.8.a.050 Gender differences in mood spectrum: clinical aspectsCarlini, M. / Bevilacqua, L. / Rucci, P. / Baldini, A. / Carmassi, C. / Golia, F. / DellOsso, L. et al. | 2006
- S563
-
P.8.b.001 Prevalence rates of major mental disorders in mental health related facilities in KoreaCho, S. J. / Park, J. I. / Bae, J. N. / Hahm, B. J. / Lee, J. Y. / Cho, M. J. et al. | 2006
- S564
-
P.8.b.002 Acetylcholine-mediated regulation of secretory cells is associated with calcium release from endoplasmic reticulum via InsPS-sensitive ion channelsKopach, O. V. / Kruglikov, L. A. / Voitenko, N. V. / Fedirko, N. V. et al. | 2006
- S565
-
P.8.b.004 Synergetic effect of P1 and muscarinic receptors activation - new mechanism of autoregulation of submandibular salivary cells?Fedirko, N. V. / Kopach, O. V. / Kruglikov, L. A. / Voitenko, N. V. et al. | 2006
- S566
-
P.8.b.006 Involvement of a2-adrenoceptors in the local peripheral anti-hyperalgesic effect of carbamazepineTomic, M. / Vuckovic, S. / Stepanovic-Petrovic, R. / Ugresic, N. / Prostran, M. / Boskovic, B. et al. | 2006